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Abstract 
 
Biocides are chemical agents, generally with a broad-spectrum of 
activity, used to destroy, render harmless, prevent the action of, or 
otherwise exert a controlling effect on any harmful organism. Biocidal 
products comprise several chemical groups. Among the most commonly 
used are alcohols, aldehydes, biguanidines (e.g. chlorhexidine), phenols 
(e.g. triclosan) and quaternary ammonium compounds (e.g. benzalkonium 
chloride).  
Although some of the biocides were discovered many years ago, 
their generalised use began only some decades ago. They are used for 
cleaning and/or disinfecting in many different environments, such as in 
hospital facilities, veterinary facilities, food and pharmaceutical industry 
sites and in our homes. Biocides are also incorporated in several products 
as preservatives, such as deodorants, body creams and soaps. Some of 
the environments where biocides are applied are shared with enterococci. 
Enterococci are Gram-positive lactic acid bacteria. They are 
commensal bacteria and natural inhabitants of the gastro-intestinal tract of 
humans and other animals. Enterococcus faecalis and E. faecium are the 
most common species found in this habitat. Enterococci are robust 
bacteria which are able to grow under very different conditions of pH, 
temperature, etc. These characteristics allow them to grow/survive in 
many different environments, such as sand, plants, water, hospitals, food 
industry, cheese and meat. These bacteria are also responsible for 
nosocomial infections and have intrinsic resistance to some antibiotics 
(such as certain -lactams, clindamicyn, some aminoglycosides) and 
acquired resistance to others (such as chloramphenicol, erythromycin, 
tetracycline, high-level aminoglycoside and vancomycin). Vancomycin 
resistant enterococci (VRE) are of great concern as this antibiotic is used 
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as one of the last resort treatments for multiple antibiotic resistant 
enterococci.  
The way these bacteria interact with biocides or respond to them 
has not been totally investigated. The studies so far published concerning 
this issue have essentially investigated the minimal inhibitory 
concentration (MIC) and minimal bactericidal concentration (MBC) values 
for such compounds. 
In this work, three of the most commonly used biocides were 
studied: benzalkonium chloride (BC), chlorhexidine (CHX) and triclosan 
(TCS). We investigated the role of EFA0010 gene, annotated for E. 
faecalis V583 as a putative SMR transporter, as a tolerance mechanism to 
biocides. This gene, named qacZ, was constitutively expressed and it was 
involved in the response of E. faecalis V583 to BC, but not to CHX or 
ethidium bromide. The susceptibility of enterococci isolated from different 
environments (clinical, veterinary and dairy products) to biocides was also 
determined by MIC assay and the values obtained were similar to those 
already described in the literature. The dissemination of the qacZ gene 
was also investigated in these isolates. No correlation was found between 
the MIC values for BC and CHX and the presence of this gene.  
Similarly, no association was observed between the MIC values for 
the same biocides, plus TCS, and resistance to vancomycin. Several 
experiments (such as growth curves in the presence of the biocides, 
relative fitness assays, exposure to biocides for a certain period of time) 
were performed in order to understand whether  there was any survival 
advantage for a vancomycin-resistance enterococcus  (VRE) in the 
presence of biocides or if these compounds can  select  VRE strains over 
vancomycin-susceptible enterococci (VSE) strains. From the obtained 
results, VRE strains were found to present no advantage in the presence 
of BC, CHX and TCS. 
v 
An unexplored environment, concerning biocides susceptibility 
patterns and enterococci, was analysed. Dust samples from Portuguese 
swine breeding facilities were collected and enterococci were isolated 
from them. The strains were identified and characterized regarding biocide 
tolerance to BC and CHX. From the same samples, VRE were also 
isolated, identified and characterized. Once more, no association was 
found between vancomycin resistance and tolerance to biocides.  
The work herein presented offers a new approach to enterococci 
response to biocides. The first description of a gene involved in the 
response to a quaternary ammonium compound is given, as well as its 
dissemination in several environments where enterococci are found. The 
possible association between vancomycin resistance and biocides was 
thoroughly investigated. VRE had no survival advantage in the presence 
of these compounds when compared to VSE. Biocides are used in the 
different explored environments for cleaning and disinfection, but no 
connection between the MIC values for the tested compounds and 
vancomycin resistance was observed. The use of these compounds does 
not select VRE strains either in clinical or in veterinary environments.   
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Sumário 
Os biocidas são agentes químicos, geralmente com um largo 
espectro de actividade, utilizados para eliminar, atenuar, impedir a acção 
de, ou controlar microrganismos prejudiciais. Agrupam-se em vários 
grupos químicos, dentro dos quais os mais comuns são: álcoois, aldeídos, 
biguanidas (ex.: clorexidina), fenóis (ex.: triclosan) e compostos 
quaternários de amónia (ex.: cloreto benzalcónio). 
Embora muitos biocidas tenham sido descobertos há muitos anos 
atrás, o seu uso generalizado aumentou nas últimas décadas. São 
usados para limpar e/ou desinfectar ambientes muito diferentes, tais 
como instalações hospitalares, instalações veterinárias, indústria 
alimentar e farmacêutica e nas nossas casas. Os biocidas podem 
também ser incorporados como conservantes em alguns produtos tais 
como desodorizantes, cremes para o corpo e sabonetes. Alguns dos 
ambientes onde os biocidas são utilizados são partilhados com 
enterococos.   
Os enterococos são bactérias Gram-positivas, ácido lácticas, 
comensais humanas e que habitam o tracto intestinal humano e de outros 
animais. As espécies mais comuns neste habitat são Enterococcus 
faecalis e Enterococcus faecium. Dada à sua robustez, os enterococos 
são capazes de crescer em diferentes condições de pH e temperatura, o 
que lhes permite crescer/sobreviver em ambientes muito diferentes, tais 
como areias, plantas, águas, hospitais, indústria alimentar, queijos e 
carne. Estas bactérias são também responsáveis por infecções 
nosocomiais, possuindo resistência intrínseca a alguns antibióticos (como 
por exemplo: alguns -lactâmicos, clindamicina, alguns aminoglicosideos) 
e resistência adquirida a outros (tais como cloranfenicol, eritromicina, 
tetraciclina, aminoglicosideos de alto nível e vancomicina). A vancomicina 
constitui um dos últimos recursos no tratamento contra enterococos multi 
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resistentes, pelo que o aparecimento de enterococos resistentes à 
vancomicina constitui um factor de enorme preocupação.  
Ainda não está totalmente esclarecido o modo como estas 
bactérias interagem ou respondem aos biocidas. Os estudos até agora 
publicados sobre este assunto debruçaram-se essencialmente sobre 
valores de concentração inibitória mínima (CIM) e de concentração 
bactericida mínima (CBM) para estes compostos.  
Neste trabalho foram estudados três dos biocidas mais utilizados, 
cloreto benzalcónio, clorexidina e triclosan. Foi estudado o papel do gene 
EFA0010, anotado para E. faecalis V583 como um transportador putativo 
SMR, como um mecanismo implicado na tolerância desta bactéria aos 
biocidas. Este gene, nomeado qacZ, é expresso constitutivamente, está 
envolvido na resposta do E. faecalis V583 ao cloreto benzalcónio, mas 
não à clorexidina nem ao brometo de etídio. Foi determinada a 
susceptibilidade de enterococos isolados de diferentes ambientes 
(clínicos, veterinários e produtos lácteos) aos biocidas por ensaios de 
concentração inibitória mínima. Os valores obtidos foram muito 
semelhantes aos já descritos na literatura disponível. A disseminação do 
gene qacZ foi também investigada nestes isolados. Não foi encontrada 
nenhuma associação entre o valor de CIM para o cloreto benzalcónio e 
para a clorexidina e a presença deste gene. 
Também não foi encontrada nenhuma associação entre os valores 
de CIM para o cloreto benzalcónio, a clorexidina e o triclosan, e a 
resistência à vancomicina em enterococos. Com o objectivo de 
compreender se enterococos resistentes à vancomicina têm alguma 
vantagem de sobrevivência na presença de biocidas ou se estes 
compostos podem estar a seleccionar estirpes de enterococos resistentes 
à vancomicina em relação a estirpes susceptíveis a este antibiótico, foram 
efectuadas vários ensaios, nomeadamente curvas de crescimento na 
presença dos biocidas, ensaios de “fitness” e exposição aos biocidas por 
viii 
um determinado período de tempo. Os resultados obtidos permitem-nos 
concluir que as estirpes resistentes à vancomicina não apresentam 
qualquer vantagem na presença de cloreto benzalcónio, clorexidina ou 
triclosan. 
Um ambiente inexplorado foi também analisado relativamente ao 
padrão de susceptibilidade a biocidas. Amostras de pó de suiniculturas 
Portuguesas foram recolhidas e destas isolaram-se enterococos. As 
estirpes foram identificadas e caracterizadas em relação à sua tolerância 
ao cloreto de benzalcónio e à clorexidina. Das mesmas amostras foram 
isolados e identificados enterococos resistentes à vancomicina, e 
caracterizados quanto à sua susceptibilidade aos biocidas. Mais uma vez, 
não foi encontrada nenhuma associação entre a resistência à 
vancomicina e a tolerância aos biocidas.  
O trabalho aqui apresentado revela novos factos no que respeita à 
resposta dos enterococos aos biocidas. É feita a primeira descrição de 
um gene envolvido na resposta a um composto quaternário de amónia, 
assim como a sua disseminação em diversos ambientes onde os 
enterococos são encontrados. A possível associação entre resistência à 
vancomicina e biocidas foi também investigada. Enterococos resistentes a 
este antibiótico não apresentam qualquer vantagem de sobrevivência na 
presença destes compostos, quando comparados com enterococos 
susceptíveis à vancomicina. Os biocidas são usados para limpeza e 
desinfecção nos diferentes ambientes estudados, no entanto não foi 
encontrada nenhuma ligação entre o valor de CIM para os compostos 
estudados e a resistência à vancomicina. O uso destes compostos não 
está a seleccionar enterococos resistentes à vancomicina nem em 
ambiente clínicos, nem em ambientes veterinários. 
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1. Biocides 
 
1.1 Definitions 
Biocide is a general term describing a chemical agent defined as 
active substances and preparations containing one or more active 
substances, put up in the form in which they are supplied to the user, 
intended to destroy, render harmless, prevent the action of, or otherwise 
exert controlling effect on any harmful organism by chemical or biological 
means (17). Biocides usually have a broad spectrum of activity in contrast 
to antibiotics, which have a narrower range of antimicrobial activity. The 
term is used in nonmedical applications (5,32). Because biocides range in 
antimicrobial activity, other terms may be more specific, including “-static”, 
referring to agents which inhibit growth (e.g., bacteriostatic, fungistatic and 
sporistatic) and “-cidal”, referring to agents which kills the target organism 
(e.g., sporicidal, virucidal and bacteriocidal). (31) 
Biocides can be used as antiseptics – applied to the skin or 
mucous membranes to destroy or inhibit the growth of microorganisms 
(e.g. health care personnel hand washes and surgical scrubs); 
disinfectants – applied to inanimate objects or surfaces to destroy harmful 
microorganisms (can be sporostatic, but not necessary sporicidal); and 
preservatives – incorporated into medications or fluids and food to prevent 
microbial growth (31, 63). 
 
1.2 History 
Biocides (antiseptics, disinfectants and preservatives) and other 
antimicrobial agents have been used in various forms for centuries. Early 
empirical approaches stored potable water in copper and silver vessels; 
used vinegar and honey for cleaning injuries; balsams as natural 
preservatives in mummification; and drying, salting and spices for food 
preservation. Later, a quantitative method for chemical preservation was 
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developed; it compared various salt solutions with a standard (sea salt) for 
their capacity of preservation. Alcohol has been used for over 2000 years 
as an antimicrobial agent, although it was not recognized as such until 
recently. Wine was used to heal all kind of injuries, but its concentration 
was very low to be used as an antiseptic. Time passed by and the 
concentration of this compound in wine and other alcoholic drinks 
increased. There are some reports of brandy used to clean and disinfect 
wounds. The Portuguese surgeon A. M. Barbosa, reported a mortality rate 
of only 10% for 243 amputations using alcohol in a Lisbon hospital during 
1855 and 1866 and only one death in 14 tight operations. Later in 1903, 
Harrington and Walker showed that a 60% to 70% alcohol solution was 
the most effective, although it did not kill bacterial spores (4). 
There are reports from 19th and early 20th, of the use of iodine as a 
wound disinfectant, of chloride water in obstetrics, of phenol as a wound 
dressing and in antiseptic surgery, and the claimed sporicidal activity of 
mercuric chloride. Curiously, phenol and chloride were first used as 
deodorants to prevent the foul odors of sewage and garbage. Quaternary 
ammonium compounds (QACs) were introduced in the earliest 1900s, 
while chlorhexidine was more recently introduced. In 1945 the most 
common used biocides were phenolic compounds, organomercurials, 
iodine, alcohol, formaldehyde, hydrogen peroxide, silver compounds and 
dyes (Table 1). Some of these are still used nowadays. The most 
important biocides used after 1945 include QACs, biguanides 
(chlorhexidine), biphenols (triclosan), aldehydes (glutaraldehyde) 
paracetic acids, among others. (4, 52, 55).  
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Table 1. Biocides and their introduction into clinical practices 
Biocide 
Discovery or 
 first description 
Introduction/application 
 
Alcohols 
 
BC Early AD 
Chlorine 
     Sodium hypochlorite 
     Chlorine dioxide 
1774 
1789 
1925 
1847 
1827 
1946 
 
Iodine 
     Iodophors 
 
1812 
1949 
 
1816 
1956 
 
Hydrogen peroxide 
 
1818 
 
1891 
 
Formaldehyde 
 
1867 
 
1894 
 
Phenol 
 
1834 
 
1867 
 
Triclosan 
 
1906 
 
Early 1970s 
 
QACs 
 
1856/1916 
 
1933 
 
Chlorhexidine 
 
1946 
 
1954 
 
Glutaraldehyde 
 
1904 
 
1960s 
 
Acridines 
 1913 
Adapted from (52); BC - Before Christ; AD - Anno Domini (After Christ) 
 
The 20th century was very rich in chemical advances and including 
the discovery and application of new biocides that we use in so many 
different ways. They protect our food from the action of microorganisms; 
preserve many of our products; protect our body from micro invaders. 
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Nowadays their used is generalized in the hospital environment, food 
industry, veterinary medicine and even in our homes. 
 
 
1.3 Chemical groups and active molecules in biocidal products 
The number of biocides in use is large. They can be used alone or 
in combination with a variety of products. During the research work for the 
elaboration of this thesis, the three biocides studied were benzalkonium 
chloride, chlorhexidine and triclosan. Their chemical group will be 
described in more detail; other important biocide chemical groups are 
summarised in Table 2.  
 
 
1.3.1 Biguanides 
Biguanides are compounds that contain the C2HN7 ligand. The 
most common active molecules are: 
  
  Chlorhexidine 
  Alexidine 
  Polymeric biguanides 
 
These compounds are used as antiseptics, disinfectants, 
preservatives and antiplaque agents. They have a broad-spectrum of 
activity, with rapid action against Gram-positive and Gram-negative 
bacteria; they are less active against fungi (including yeast and molds). 
They are not sporicidal, although they do inhibit the outgrowth of spores 
and some sporicidal activity can be achieved by combination with other 
biocides or at higher temperatures (>70ºC). Their activity against virus is 
also limited (31, 33, 36).  
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1.3.1.1 Chlorhexidine 
 
 
 
 
 
 
 
Chlorhexidine (CHX) is the most commonly used biguanide with a 
broad range of application: antimicrobial soaps, wound dressings, mouth 
washes, hair care products, surface disinfectants and preservatives (for 
example, contact lens storage solution). It is used for surface disinfection 
at 0.5% to 4%, for antisepsis at 0.02% to 4% and for preservation at 
0.0025% to 0.01% (31, 33). Chlorhexidine has a broad-spectrum of 
activity, produces minimal skin irritation and its substantivity on skin and 
mucous membranes. Although in few cases, some sensitivity to 
chlorhexidine has been described. Chlorhexidine plays an important role 
in the control of hand transmission pathogens in hospital. It has the ability 
to remain present at a bacteriostatic concentration on skin even after hand 
washing. Chlorhexidine and other biguanides can be inactivated by 
nonionic surfactants, in some soaps, hand creams and inorganic water 
contaminants (33).  
Chlorhexidine activity is pH dependent and is largely reduced in 
the presence of organic matter. Its major target is the cytoplasmatic (inner) 
membrane. Low concentrations of this compound affect the membrane 
integrity, while high concentrations coagulate the cytoplasm. Primarily, 
chlorhexidine acts on cell membranes, provoking loss of structure and 
function. It is rapidly absorbed through bacterial and fungal cell walls and 
damages the inner cell membrane, causing cytoplasm leakage and 
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precipitation of proteins and nucleic acids (31, 33). This biocide shows a 
rapid action against Gram-positive and Gram-negative bacteria. It is less 
effective against fungi, including yeast and molds. It has no sporicidal 
activity, although it can inhibit (but not the germination of) spores. 
Mycobacteria are generally less susceptible to chlorhexidine, 
Mycobacterium avium-intracelluare is considerably more tolerant than 
other mycobacteria. The antiviral activity of chlorhexidine is variable; it is 
more effective against lipid-enveloped viruses and cannot inactivate 
nonenveloped virus, such as rotaviruses, hepatitis A virus or polioviruses. 
It is believed that the outer coat of virus is the major target of chlorhexidine 
(31, 33). 
 
 
1.3.2. Phenolics 
Phenolics are a class of alcohol compounds with one or more 
hydroxyl groups attached to an aromatic hydrocarbon ring. A wide variety 
of phenolics are used for disinfection, antisepsis and preservation (31):  
 
  Coal tar 
   Cresol 
   Phenol 
   Xylenols 
   Naphthols 
 
 
  Non-coal tar phenols 
   2-Phenylphenol 
   4-Hexylresorcinol 
 
  Halogenated phenols 
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   Chlorophenol 
4-Chloro-3,5-dimethylphenol (chloroxylenol; para-
chloro-meta-xylenol; PCMX) 
2-Nitrophenol 
   4- Nitrophenol 
   
  Bisphenols 
   Hexachlorophene 
   Triclosan (2,4,4’-trichloro-2’-hydroxydiphenyl ether) 
 
Other phenol derivatives 
   Salicylic acid 
   2,3-Diaminophenol 
 
Most phenolic compounds have a broad-spectrum of activity 
against bacteria (generally more efficient against Gram-positive than 
Gram-negative), fungi and viruses. Tuberculocidal activity has also been 
observed. They are sporistatic, with little or no sporicidal activity. Phenolic 
compounds are cellular poisons, but they also have cell membrane-active 
properties. At low concentrations, they inactivate membrane enzyme 
functions and increase the cell wall permeability and they induce the 
progressive leakage of intracellular constituents. At high concentrations, 
phenols have multiple effects on cell wall, cell membrane and cytoplasmic 
components, including their coagulation, causing irreversible cellular 
damages (31, 33, 36). 
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1.3.2.1 Triclosan 
 
 
 
 
 
Triclosan (TCS) is an antimicrobial agent used for several 
purposes for more than 20 years (57). It is commonly used in antiseptic 
soaps, hand rinses, lotions, cleaners, shampoos, deodorants, gels and 
antiacne washes. Concentrations range between 0.1 to 2%, but higher 
concentrations can be used in higher-risk applications (33). It has a 
cumulative and persistent effect on skin and is neither toxic nor irritant to 
skin and mucous membranes. Triclosan is also used in mouth rinses and 
antibacterial toothpastes. It is also used as a preservative in cosmetic and 
other products, usually in combination with other biocides. Due to its 
thermal and chemical stability, triclosan has also been incorporated into 
plastics and fabrics.  
Triclosan as antiseptic can penetrate into and through skin without 
any toxic, allergenic or mutagenic effect. Its stability and activity is 
preserved in the presence of organic matter and high temperatures, 
allowing triclosan to be used as an antimicrobial barrier in textiles and 
plastics. Due to its stability and extensive use, triclosan has been found in 
the environment, raising some concern about its ecological effects (33, 
36). 
 Triclosan has a broad-spectrum of activity, it is particularly efficient 
against Gram-positive bacteria, but it is also active against Gram-negative 
bacteria and yeasts. Lower activity is observed against some enveloped 
viruses, fungi and some pseudomonads. Pseudomonas aeruginosa is 
highly resistant to triclosan. At high concentrations, this compound cause 
rapid release of the cellular components and consequently cell death; at 
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low concentrations it has more specific targets, such as the fatty acid 
biosynthesis. Triclosan blocks lipid synthesis by interacting specifically 
with the substrate binding site of FabI enoyl reductase and simulating 
enzyme’s natural substrate. It was proven that in Escherichia coli and 
mutations in or overexpression of the gene fabI (encoding for enoyl 
reductase) prevents this blockage (28, 34). This has also been observed 
in S. aureus and Mycobacteria. 
   
 
1.3.3 Quaternary ammonium compounds 
QACs are cationic surfactants (or “surface-active agents”), 
containing one quaternary nitrogen associated with at least one major 
hydrophobic substituent. The most common used are: 
 
  Benzalkonium chloride  
Cetrimide 
  
QACs are used for disinfection, antisepsis, preservation and cleaning (31). 
From an antimicrobial perspective, cationic surfactants, especially QACs, 
are the most commonly used.  
 
 
1.3.3.1 Benzalkonium chloride 
 
 
 
 
 
Benzalkonium chloride (BC) is a first-generation QAC. It consists 
of a mixture of alkyldimehtylammonium chlorides and the length of alkyl 
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chains range between C8 to C18. It is used as household, industrial and 
health care general surface disinfectant, in high-level surgical instrument 
sterilizing and disinfecting solutions. Benzalkonium chloride can also be 
used as preservative (e.g. contact lens solutions and cosmetics at 
concentration of 0.001-0.01%) (36), fabric and laundry deodorization or 
softening.  
Benzalkonium chloride provides a good cleaning and disinfection, 
being noncorrosive and nonstaining on surfaces. It has a “clean” odor and 
is regarded as nontoxic under typical conditions of use. At high 
concentrations it can be irritant to skin and mucous membranes (33). 
At concentrations above 1 mg/ml, it has a broad-spectrum of 
activity, being bactericidal (Gram-positive bacteria are usually more 
susceptible than Gram-negative bacteria) and fungicidal. Formulations 
using benzalkonium chloride and other QACs have been used to improve 
their activity against viruses and mycobacteria. This compound is 
sporistatic, but cannot inhibit the actual germination process. The primary 
target of this biocide is the bacterial and fungal cell walls and membranes. 
It is easily absorbed causing the disruption of cell wall and its structure. 
When in contact with the membrane, benzalkonium chloride reacts with its 
lipids and proteins (including enzymes), leading to loss of structure and 
function and leakage of cytoplasmic material. It also degrades nucleic 
acids (33). 
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Table 2: Biocides chemical groups and characteristics.  
 Chemical 
groups 
Active molecules Applications Spectrum of activity 
Alcohols 
Ethyl alcohol (ethanol) 
Isopropyl alcohol (isopropanol) 
Methyl alcohol (methanol) 
Benzyl alcohol 
Phenylethanol (phenylethyl alcohol) 
Bronopol (2-bromo-2-nitro-1,3-diol) 
Phenoxyethanol (phenoxetol) 
Chlorbutanol (chlorbutol) 
2,4-Dichlorobenzyl alcohol 
Antisepsis 
Disinfection 
Preservation 
Broad-spectrum activity against 
vegetative bacteria (including 
mycobacteria), viruses and fungi. 
Not sporicidal, however inhibit 
sporulation and spore 
germination. 
 
Aldehydes 
Glutaraldehyde (pentanedial) 
Formaldehyde (methanol) 
Ortho-phthlaldehyde 
Sterilization 
Disinfection 
Preservation 
Virucidal, bactericidal, 
mycobactericidal, fungicidal and 
also sporicidal (at low 
concentrations sporistatic). 
Anillides 
Triclocarban 
Salicylanilide 
Diphenylureas (carbanilides) 
Tribromsalan 
Antisepsis 
Preservation 
Bacteriostatic and fungistatic 
agents; more effective against 
Gram-positive bacteria then 
Gram-negative. 
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Table 2: Continued.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from (31, 33, 36 54, 60).
Chemical 
groups 
Active molecules Applications Spectrum of activity 
Diamidines 
Propamidine 
Dibromopropamidine 
Antisepsis 
Preservation 
Effective against bacteria, fungi 
and parasites; Gram-positive are 
more susceptible to them than 
Gram-negative and fungi. 
Halogens and 
Halogen-
releasing 
agents 
Chlorine compounds 
Iodine compounds 
Bromide compounds 
Antisepsis 
Disinfection 
Broad-spectrum activity against 
bacteria, fungi and virus; some are 
effective against mycobacteria. 
Metals 
Silver 
Copper 
Antisepsis 
Disinfection 
Preservation 
Effective against bacteria, fungi 
and viruses 
Peroxygens 
Hydrogen peroxide 
Paracetic acid 
Ozone 
Sterilization 
Disinfection 
Antisepsis 
Preservation 
Broad-spectrum of activity against 
bacteria, viruses, mycobacteria, 
fungi and bacteria spores; more 
effective against Gram-positive 
than Gram-negative. 
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1.4 Biocide activity 
 
1.4.1 Mechanisms of action 
The use of biocides has increased in the past years in very 
different environments, such as health-care and veterinary facilities, food- 
and pharmaceutical industries and even in our homes. Biocides may act at 
one or several generalized targets within the cell, while antibiotics have a 
specific target. This non-specificity of biocides reduces their selectivity and 
negates their use in therapy (23). Some years ago, it was discovered a 
biocide with a single target site (triclosan) (34). Used concentrations of 
biocides are generally high, so they cause membrane disruption or 
inactivate a broad range of enzymes. Lower concentrations (like residual 
concentrations that may be left after cleaning and disinfection of surfaces) 
may act in the same way as antibiotics, specifically affecting one or two 
cell targets (23). Biocides vary greatly in their chemical structures, as 
already mentioned. The precise mechanism(s) of action may reflect this 
variety, although the final damage may seem quite similar (when high or 
lethal concentrations are used) (Table 3).  
When biocides and a microorganism “meet together” a sequence 
of events occurs. First the biocide binds to the cell surface, then it 
penetrates the cell wall and membrane, thus entering the cytoplasm, 
where it interacts with cellular proteins or nucleic acids. The lethal effect is 
due to cellular damage cause by the biocide at some stage of this process 
(27). Mechanisms of action depend on the chemical nature of the biocide, 
the microorganism used in their evaluation and the test conditions (60). 
Some biocides are chemically reactive and bind covalently to proteins and 
peptidoglycan in cell wall; others are membrane-active and by physical 
interaction with the membrane components disrupt the structure of the cell 
membrane, releasing cell contents. Some act upon enzymes in the 
membrane or cytoplasm or upon nucleic acids. 
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The action of a biocide may be defined according to the bacterial 
structure which it is acting. Therefore, three levels of interaction can be 
described: a) interaction with outer cell components (cell wall); b) 
interaction with cytoplasmic membrane and c) interaction with cytoplasmic 
constituents (14, 27, 30).  
 
1.4.1.1 Interaction with outer cell components 
In general, Gram-negative bacteria are less susceptible to biocides 
than Gram-positive, due to their outer membrane. There are several 
compounds that act specifically against this barrier, such as chlorhexidine, 
QACs, phenols, chlorine-releasing agents, by increasing its permeability. 
Some of these compounds are thought to damage the cell wall and outer 
membrane, thus promoting their own uptake and being able to reach their 
target site(s) at cytoplasmic membrane or within the cytoplasm. 
Ethylenediaminetetraacetic acid (EDTA) binds to divalent cations, 
especially Mg2+, releasing lipopolysaccharides molecules and thus 
provoking loss of the permeability function of the outer membrane. Some 
aldehydes are very reactive molecules and their cross-link to the cell wall 
can result in a bactericidal effect. Hypochlorite induces lysis in Gram-
negative bacteria, by apparently affecting the cell wall. Phenol, formalin 
and mercuric chloride also affect this cellular structure (14, 27, 30, 31, 60). 
Chapter I 
 
17 
Table 3. Biocides: targets and mode of action. 
Adapted from (30, 31, 33 60).
Biocide Target and mechanism(s) of action 
Alcohols 
Penetrating agents that cause loss of cellular membrane function, releasing intracellular components, denaturing proteins and 
inhibiting DNA, RNA, protein and peptidoglycan synthesis 
Aldehydes 
Cross-linking agents that interact with the unprotonated amines in outer cell wall, leading to loss of cell wall function. Inhibition 
of DNA and RNA synthesis as result of cross-linkage of thiol, sulphydryl and amino groups. 
Anillides Adsorb to and destroy the semipermeable character of the cytoplasmic membrane. 
Biguanides 
Membrane-active agent that damage cell wall and outer membrane, collapsing the membrane potential and intracellular 
leakage. Enhanced passive diffusion mediates further uptake, leading to cytosol coagulation. 
Diamidines Interfere with cell membrane and structure; precipitation of DNA, RNA and nucleoside-containing compounds. 
Halogens and 
halogen-realising 
agents 
Highly active oxidizing agents that destroy cellular activity of proteins. Disrupts oxidative phosphorylation and membrane-
associated activities. Iodine reacts with cysteine and methionine thiol groups, nucleotides and fatty acid, leading to cell death. 
Metals Cause protein desnaturation, DNA degradation and cell wall disruption. 
Peroxygens 
Hydrogen peroxide produces hydroxyl free radicals that function as oxidants which react with lipids, proteins and DNA. Cell 
permeability is increased due to the targeted of sulfhyldryl groups and double bonds. 
Phenols 
Increase cytoplasmic membrane permeability, resulting in progressive leakage of intracellular constituents. Permeability to 
protons leads to dissipation of proton motive force and uncoupoling of oxidative phoshorylation, coagulation of cytoplasm and 
cell lysis. In the particular case of triclosan, it binds to enoyl-acyl carrier protein reductase, inhibiting fatty acid biosynthesis. 
QACs 
Damage cell wall and cytoplasmic membrane, by binding to phospholipids and provoking loss of structural integrity of 
cytoplasmatic membrane. Enhances further uptake and induces leakage of intracellular components and cell lysis. 
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1.4.1.2 Interactions with cytoplasmic membrane 
The so called “membrane active agents” is applied to biocides 
active at the cytoplasmic membrane level. These include phenols, 
biguanides, QACs, alcohols, parabens and polymxyxins, and due to their 
different chemical structures, their effect against cytoplasmic membrane 
must be different. We can group the effects of these biocides in three 
different categories: cytoplasmic membrane, proton motive force (PMF) 
and enzymatic systems.  
Cytoplasmic membrane. Disruption of the cytoplasmic membrane usually 
implies leakage of intracellular components. Phenols, cresols and their 
chlorinated derivates induce leakage of intracellular materials in bacteria. 
Chlorhexidine initially causes a high rate of leakage of intracellular 
components, but in higher concentrations it coagulates the cytosol. 
Polyhezamethylene biguanide causes domain formation of the acidic 
phospholipid, causing cytoplasmic membrane disruption. QACs, as well as 
chlorhexidine, also induce the leakage of intracellular components, and it 
is believed that they combine with the membrane phospholipids, thus 
causing cytoplasmic membrane disruption. Anionic agents, organic acids 
and esters, may also induce leakage of intracellular components, by 
causing membrane disruption. Ethanol causes release of intracellular 
components and disorganizes the membranes (14, 27, 31, 30, 60). 
Proton motive force. Several agents cause dissipation of the proton motive 
force (PMF), which is the way the energized state of bacterial membranes 
is expressed. PMF is composed of an electrical potential and a proton 
gradient that bacteria maintain across their cytoplasmic membrane to 
drive vital processes such as active transport of solutes, oxidative 
phosphorylation and ATP synthesis. The proton motive force is generated 
by oxidation-reduction reactions occurring during electron transport. 
Several different types of biocides affect the proton motive force across 
the membrane, namely lipid-soluble phenols, phenoxyethanol, organic 
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acids and esters, by accelerating the movement of protons, inhibiting the 
active uptake of amino and oxo acids, changing pH and denaturing 
proteins. TCS and other cationic compounds also discharge the 
membrane potential component (14, 27, 31, 30, 60). 
Enzymatic systems. Some biocides interact with enzymes embedded in 
the cytoplasmic membrane. Ethanol inhibits enzymes involved in 
glycolysis, fatty acid and phospholipid synthesis and solute uptake, 
causing membrane disruption. Other compounds such as metals (copper 
and silver), interact with the thiol group of proteins, producing cell 
inactivation or inhibition. High concentrations of chlorhexidine inhibit 
membrane-bound adenosine triphosphatase. Triclosan (in low 
concentrations) has effect upon fatty acid biosynthesis, by targeting the 
enoyl-acyl carrier protein redutase (FabI) in E. coli and Mycobacterium 
smegmatis. (28, 27, 30, 34). 
 
1.4.1.3 Interactions with the cytoplasmic constituents 
Compounds like dyes and acridines combine with DNA, by 
intercalation of one molecule between two layers of base pairs, and can 
also block protein synthesis. Ethylene oxide and formaldehyde affect 
purine nucleosides and nucleic acids, as they interfere with amino, 
sulphydryl and hydroxyl groups. Dyes, such ethidium bromide, bind to 
nucleic acids and precipitate them. Hydrogen peroxide can damage 
ribosome, although these are not its primary target site. It also forms 
hydroxyl radicals with oxidized thiol groups in proteins and enzymes. 
Ethylene oxide, propylene oxide and -propiolactone react with amino, 
carboxyl, sulphydryl and hydroxyl groups in bacterial proteins and nucleic 
acids. Aldehydes are very reactive compounds which combine with 
proteins and nucleic acids. Chlorhexidine, QACs, halogens, copper and 
silver ions, and hydrogen peroxide can cause cytoplasmic protein 
coagulation (14, 27, 30, 31, 60). 
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1.4.2 Factors influencing biocide activity 
Generally speaking, several factors influence the activity of 
biocides: period of contact, nature, number, location and condition of 
microorganism (bacteria, spores, yeast and molds, protozoa) or entity 
(prions, viruses), temperature, formulation effects, presence of organic 
matter or other interfering or enhancing materials/compounds, 
concentration and pH (51, 54). Other important aspects to take into 
account when studying the activity of biocides are related to the pre-
treatment, during and post-treatment factors (6, 55). 
 
1.4.2.1 Pre-treatment factors 
Pre-treatment factors are related to culture growth conditions. 
Bacterial cell walls are variable structures which change in response to 
growth environment. In a batch-grown culture, there are some aspects to 
take into consideration (6, 55): 
- growth medium: may influence the subsequent sensitivity of cells 
to biocides;  
- growth phase: latter phase cultures contain a high proportion of 
dead cells that will protect the viable ones; 
- pH of culture medium: cell walls of bacteria may be different 
according to the pH in which they were grown and this may lead to 
variations in response to biocides; 
- incubation temperature: different temperatures may lead to 
changes in phospholipid content or composition of spores, thus leading to 
different responses to biocides; 
- presence/absence of oxygen: few information is available on this 
parameter. 
 
When performing an experimental assay in order to study the 
susceptibility of a microorganism to biocides, it is important to take these 
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factors into account. The cultures must be always incubated in the same 
conditions and the growth medium used must be the same (even from the 
manufacture). 
 
1.4.2.2 During treatment factors 
Several factors may affect the activity of an antibacterial agent 
during treatment. Their effects maybe on the bacterial cell itself or may 
result from direct effects on the agents. Herein, will be described the most 
important ones to take into account under experimental conditions. 
 
Concentration 
 This is a major factor in biocidal activity. The concentration 
exponent (n or ) measures the effect of concentration, or dilution, on the 
activity of the biocide. To determine , it is necessary to measure the time 
required to produce a comparable degree of death of a bacterial 
suspension at two different concentrations of the biocide. 
 
 = (log t2 – log t1) / (log C1 – log C2) 
 
Where C1 and C2 represent the two concentrations and t1 and t2 the 
respective times to reduce the viable population to a similar degree. 
Biocides with high -values (e.g. phenolic compounds and alcohols) are 
largely affected by changes in concentration (or dilution), whereas those 
with low -value (e.g. QACs, chlorhexidine, glutaraldehyde) are less 
influenced by dilution. Concentration exponent: benzalkonium chloride 3.5; 
chlorhexidine 1.9; ethanol 4.5 and phenol 5.8 (15).Thus, concentration is 
quite important in clinical and other environments, where residues of 
biocides remain and must be considered and in order to determine 
accurately the lethal activity of a biocide. “Wrong” concentration may lead 
to biocide failure. (6, 55) 
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Temperature 
 The activity of a biocide usually increases when the temperature at 
which it is acting is increased. The effect of temperature can be calculated 
from the following formula: 
 
 (T2
- T
1
) = k2 / k1 
 
Where k2 and k1 are the death rate constants at temperatures T2 and T1, 
respectively. The temperature coefficient () refers to the effect of 
temperature per 1 ºC increments, and is nearly always between 1.0 and 
1.5. Due to that, is more common to use 10 (or Q10) value, which is the 
change of activity per 10 ºC rise. Some temperature coefficients (Q10) are: 
2.9 to 5.8 for benzalkonium chloride; 3 to 16 for chlorhexidine; 45 for 
ethanol and 5 for phenol (15). Biocides respond differently to temperature 
variations, and this is an important factor to take into account when 
performing experimental assays or any cleaning and disinfection 
procedure (6, 55). 
 
Number of microorganism cells 
 The activity of a biocide decreases when the inoculum size 
increases. This is dependent of the type of microorganism used and is 
particularly important in the production of various types of pharmaceutical 
and cosmetic products (6, 55). 
 
Type of microorganism 
 An ideal biocide should have broad-spectrum activity against both 
Gram-negative and Gram-positive bacteria, molds and yeasts. In practice, 
biocide activity varies greatly between different types of microorganisms 
and it might also differ between different strains of the same species. 
Generally, Gram-positive bacteria, due to the composition of their cell 
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envelope, are more sensitive to biocides than Gram-negative and prions 
are on the top of the list in what concerns biocide low susceptibility (Figure 
1). 
Bacteria can be surrounded by a capsule and secreted materials. 
These may play an important role in decrease susceptibility to biocides. 
The outer membrane of Gram-negative and the cell wall of mycobacteria 
act as permeability barriers and are responsible for intrinsic resistance of 
these bacteria to some biocides (6, 30, 55, 49). 
 
Environmental pH 
 The biocidal activity is influenced by environmental pH, as changes 
in ionic status alter the interaction with the target groups on the microbial 
cell. Several biocides have an optimum pH range of activity. 
Glutaraldehyde and cationic biocides (like chlorhexidine and QACs) are 
most effective at alkaline pH, whereas hypochlorites and phenols are most 
potent at acid pH. Some biocides optimal pH values are: 4-10 for 
benzalkonium chloride; 5-8 for chlorhexidine; <7 for ethanol and phenol  
(15). Changes in environmental pH can also produce changes in charge 
distribution of bacterial cell surface, thus affecting the uptake of charged 
biocide. A pH value increment, increases the number of negatively 
charged groups on the bacterial cell surface, thus promoting the degree of 
binding of positively charged molecules (e.g. QACs) (6, 55). 
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Figure 1. Classification of microorganisms according to their sensitivity to biocides. 
CJD – Creutzefeld-Jacb disease agent; BSE – bovine spongiform encephalopathy agent; 
MAI – Mycobacterium avium intracellulare; HIV – human immunodeficiency virus. Adapted 
from (30, 49). 
 
Interfering substances 
 Organic matter (such as serum, blood, dirt, pus, food residues, etc) 
may interfere with the biocidal activity. This interference is usually due to 
reaction between the biocide and the organic matter, which reduces the 
biocide efficacy. Organic matter may also protect microorganism from the 
action of the biocide. In the food and dairy industries, organic matter may 
become a problem. A way to overcome this is by performing suitable pre-
cleaning before using a disinfectant or by combination of a disinfectant 
with a detergent. 
Chapter I 
25 
 The presence of non-ionic agents can also reduce the activity of 
some biocides (e.g. QACs). Significant increases in concentration of the 
biocide are required in order to inhibit microorganism in the presence of 
these agents (6). 
 
Humidity 
 Relative humidity has a great influence on the activity of gaseous 
disinfectants (e.g. formaldehyde). It is the most important factor 
influencing the activity of vapour-phase disinfectants (6, 55). 
 
1.4.2.3 Pos-treatment factors 
 There are several factors that influence the recovery of 
microorganisms exposed to a biocide: composition and pH of recovery 
medium, removal of the biocide, temperature and period of incubation and 
composition of the diluents used for serial dilutions in viable cells counts 
(6). 
 
 
1.5 Mechanisms of bacterial resistance to biocides 
Bacterial response to biocides is usually dependent of its chemical 
nature and other factors already mentioned above. Mechanisms of 
bacterial resistance are divided in two main types: intrinsic and acquired. 
Intrinsic resistance is due to some inherent characteristic of the cells, 
while acquired resistance is obtained after a previous exposure of the 
sensitive cell to the antimicrobial agent (31, 47, 50).  
 
1.5.1 Intrinsic resistance 
Intrinsic resistance is defined as a natural (innate) chromosomally 
controlled property of a bacterial cell that enables it to circumvent the 
action of a biocide. It is more commonly found in Gram-negative bacteria, 
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mycobacteria and bacterial spores (46, 47). This intrinsic resistance has 
contributions from several cell compartments, namely the outer layers of 
the cell and lipopolysaccharides, acting as a permeability barrier; charge 
property of the cell surface, causing bacterial resistance to positively 
charge biocides; the presence of efflux pumps, which decreases the 
intracellular concentration of the biocides; and enzymatic transformations.  
Gram-Positive bacteria such as enterococci, staphylococci and 
streptococci are generally more sensitive to biocides than Gram-negative 
bacteria. Enterococci are generally less sensitive to biocides than are 
staphylococci (31); although the exact mechanism remains unclear, but 
could involve reduced uptake of biocides. The outer membrane of Gram-
negative bacteria acts as a barrier limiting or preventing the entry of 
several biocides, thus being responsible for confer intrinsic resistance. 
Pseudomonas are particularly resistant to some biocides (31). They 
tolerate high concentrations of QACs, chlorhexidine and triclosan. These 
bacteria have differences in the lipopolysaccharide composition and in the 
cationic content of the outer membrane. Members of the genus Proteus 
have high resistance to chlorhexidine, QACs, EDTA and diamides due to 
the presence of a less acidic type of outer membrane lipopolysacharides 
(31). 
 
1.5.1.1 Physiological (phenotypic) adaptation  
Biofilms  
Biofilms are defined as a group of microorganisms attached to a 
surface and organized within an extensive exopolysaccharide exopolymer 
(47). Biofilms can be communities of several different species, or mixed 
phenotypes of the same organism. Its formation is a multistage process in 
which microbial cells adhere to the surface (initial reversible attachment), 
while the subsequent production of an extracellular matrix (containing 
polysaccharides, proteins and DNA) results in a firmer attachment (61). 
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Bacteria residing in bioflims are 10- to 100-fold more resistant to biocides 
than planktonic bacteria. There are several reasons that may justify this: 
(i) difficult access of the biocide to the inner part of the biofilm; (ii) different 
physiology of bacteria at different parts of the biofilm due to different 
nutritional conditions; and consequently (iii) different growth rates within 
the depths of the biofilm (iv) chemical interaction between the biocide and 
the biofilm itself; (v) modulation of the microenvironment; (vi) production of 
degradative enzymes (and neutralizing chemicals); and (vii) genetic 
exchange between cells in a biofilm. However, biofilms can change 
according to the microorganism and biocide in question. Bacteria removed 
from a biofilm and recultured in a culture media, are generally as 
susceptible as the “normal” planktonic cells of that species (31, 47). 
 Biofilm formation and consequent decreased susceptibility to 
biocides, has important implication in clinical environment (biofilm 
formation in catheters, artificial joints and other medical devices) leading 
to patient infections, and in several industries (biofilm formation in 
surfaces of storage tanks, pipelines, filtrations systems and other 
machineries), leading to product contamination.  
Biofilms provide an important example of how physiological 
adaptation can play a role in conferring intrinsic resistance. 
 
1.5.2 Acquired resistance  
Acquired resistance results from genetic changes in a cell and 
arises either by mutation or by the acquisition of genetic material 
(plasmids, transposons) from another cell (47). Acquired, non-plasmid-
encoded resistance can appear when bacteria are exposed to a gradually 
increasing concentration of a biocide. Such resistance is usually unstable 
and may be lost if cells are grown in a biocide-free medium. 
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1.5.2.1 Plasmid-mediated resistance to biocides 
 There are some possible plasmid-mediated resistance 
mechanisms to biocides. 
 
Inactivation 
 Biocide inactivated as result of an enzymatic modification. The 
most common example of biocide inactivation involves mercury and other 
organomercury compounds. Although, mercurials are no longer used as 
disinfectants, phenylmercuric salts and thiomersal are still used in some 
types of pharmaceutical products. The mechanism of resistance to 
mercury involves detoxifying reductase and hydrolase enzymes. 
Resistance to formaldehyde has also been reported in some bacteria as 
associated with formaldehyde dehydrogenase (provoking aldehyde 
degradation) (47, 48). 
 
Impermeability and cell surface alterations 
Biocide uptake and accumulation is reduced in case of 
impermeability and cell surface alterations. One example is the plasmid-
mediated resistance to silver salts (still used as topical antimicrobial 
agents). Although, it is not totally understood, it is believed that the 
mechanism is by reducing the accumulation rather than silver reduction. 
This reduced uptake as also been studied for QACs and chlorhexidine, but 
results are not conclusive. There are some reports of plasmid-encoded 
changes in the outer membrane proteins of some Gram-negative bacteria 
leading to reduced susceptibility to formaldehyde and other industrial 
biocides (31, 48). 
 
Efflux 
 Efflux or extrusion of cytotoxic drugs from the cell via membrane 
proteins is one of the most common employed resistance strategies in 
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biological systems. Those proteins act like bilge pumps and decrease the 
intracellular concentration of the drug. In prokaryotic organism the drug 
efflux process is largely conferred by pumps in which the drug extrusion is 
coupled to the influx of a proton (H+). The pumps can be categorized into 
several families: major facilitator (MF) superfamily, the small multidrug 
resistance (SMR) family, resistance/nodulation/cell division (RND) family, 
and drug/metabolite efflux (DME) family. In other pumps, the drug efflux is 
coupled to Na+ influx – multidrug and toxic compound extrusion (MATE) 
family; or gets energy from the hydrolysis of ATP – ATP-binding cassette 
(ABC) family (7, 29, 43). 
 Staphylococci are one of the most well studied bacteria concerning 
the genetic aspect of plasmid-mediated biocide resistance mechanisms. In 
these bacteria, known biocide exporters are members of the MF and SMR 
super families and include several determinants, namely: qacA, which 
encodes resistance to QACs, acridine, ethidium bromide and low-level 
resistance to chlorhexidine, qacB, which is similar but specifies resistance 
to QACs and intercalating dyes, qacC and qacD, which specify resistance 
to QACs and low-level resistance to ethidium bromide (47, 48). Biocide 
exporters in Gram-negative bacteria are in general chromosomally 
encoded, with the exception of qacE, qacE1 and qacF genes (acting 
against compounds such as QACs and ethidium bromide) (10, 44). 
 
 
1.5.3 Possible link between biocide use and antibiotic resistance 
In the last decades, we have witnessed a huge increase in the use 
of biocides. Their generalised use and sometimes misuse is causing some 
concern if they are creating cross-resistance with antibiotics. It is quite 
difficult to get a clear response to this, as the data available focus on 
specific bacteria or specific compound. Moreover, there is always a 
difference between what happens in vitro and in vivo. Biocides usually 
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have multiple target sites and the mechanism of resistance to them is 
often concentration dependent. At high concentrations, multiple structural 
and metabolic targets are involved, but at low concentrations fewer targets 
are affected. In contrast, antibiotics usually have distinct structural and/or 
metabolic targets. 
When bacteria are killed by biocides at in use concentrations, 
several target sites are involved (Figure 2a)). If very low concentrations of 
biocide are used, they may work as a nutrient. This can be useful in case 
the objective is biodegradation of the biocide. As concentration increases, 
bacteria will be affected in several targets and killed by various ways. This 
means, that at in use concentration, in order to become resistant, several 
different mechanisms would have to be involved and multiple targets 
resistance is unlikely to occur. If the biocide is diluted, as its concentration 
gets lower than its in use concentration, the susceptible targets will also 
be reduced (Figure 2b)). This may happen when a surface is cleaned or 
disinfected, as there will be areas in which bacteria will be exposed to sub 
inhibitory concentrations of biocide (22). This also happens in biofilms, as 
already mention. A gradient of concentrations is created and at some point 
there will probably be a selection pressure on a single target. If this single 
target happens to be shared with another antimicrobial agent, such as an 
antibiotic, cross resistance may occur. 
Antibiotic resistance does not rely only on target change, efflux 
mechanisms are also involved. Efflux pumps can be induced when 
bacteria are exposed to sub-lethal concentrations of antibiotics (such as 
tetracycline), but also to some biocides such as QACs and triclosan (22). 
When bacteria are exposed to low concentration of these agents, cells 
that are able to pump out such compounds will be selected. For biocides, 
this will not influence treatment outcome (as high concentrations are 
usually applied), but the use of these compounds may be selecting 
antibiotic resistant bacteria. Cationic biocides, such as biguanides and 
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QACs, get into bacterial cells by the so called “self-promoted uptake”, the 
same mechanism of cell entry of aminoglycoside antibiotics. Changes in 
the permeability of the cell wall also occur in the presence of some 
antibiotics and biocides. Therefore, adaptations against these agents may 
lead to cross-resistance. Filament formation induced in Gram-negative 
bacteria by some antibiotics (e.g. -lactams and fluoroquinolones) is also 
induced by biocides (such as acridines, phenoxyethanol and phenylethyl 
alcohol). The autolysis provoked by low concentrations of phenolics and 
inorganic and organic mercury is said to be also induced by penicillin (53). 
There is also possibility of genetic linkage between genes for biocide 
resistance and antibiotic resistance when biocide and antibiotic resistance 
genes are part of the same genetic element (44).  
Biocides play an important role in our society. They are essential in 
preventing and controlling infection in several environments and it is 
important to take into account that their use creates a certain selective 
pressure. Some actions may be taken in order to try to avoid cross-
resistance between biocides and antibiotics. Limit biocide usage to 
applications where there is demonstrable gain and a proven need for 
hygiene and prefer those that that are more rapidly neutralized at point of 
use; biocides with low chemical reactivity, such as QACs and triclosan, 
are more difficult to be neutralized. Rotation of disinfectants in hospital 
and some industries (pharmaceutical and food) has been adopted in order 
to prevent de development of bacterial resistance. Ideally, one biocide 
should be replaced by another having a different mode of action. 
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Figure 2. Each box represents a different target site. a) biocide mechanism: at in use 
concentration all targets are involved (multiplicity of target site), resistance in unlikely to 
occur. b) biocide dilution: a gradient of concentration is created, reduction in the number of 
target sites; at a certain point there will be selection of a single target, that may be shared 
with other antimicrobial agent. Adapted from (22). 
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1.5.4 Some resistance and cross-resistance described 
Biocide resistance was first recognized in 1936 by Heathman et al. 
(18) who identified Salmonella Typhi resistant to chlorine. In 1952, the 
isolation of Serratia marcescens resistant to QACs was reported by 
Chaplin (9). Dance et al. (13) reported the outbreak of Proteus mirabilis 
resistant to chlorhexidine in a general hospital in the United Kingdom. 
These strains were also resistant to some antibiotics, like gentamicin, 
trimethoprim and ampicillin. 
Some of the outbreaks described are related to contaminated 
antiseptics and disinfectants. These outbreaks usually occurred due to 
Gram-negative bacteria and mycobacteria. Some of outbreaks reported 
were related to chlorhexidine; most of them related to contaminated water 
used to prepared the solutions and/or reuse of bottles to dispense the 
biocide without adequate disinfection. There are also reports of outbreaks 
related to the use of QACs, especially benzalkonium chloride. Many of 
these were linked to the storage of this biocide with cotton or gauze, and 
others with improper dilution of its solution. Few outbreak reports are 
related to triclosan, but one was due to intrinsic contamination of the 
antiseptic soap. Pseudomonas, Burkholderia and Ralstonia were the 
genera usually involved in these outbreaks (63). 
 Triclosan, as already mentioned, inhibits the growth of some 
bacteria by targeting an enoyl reductase enzyme (FabI gene) in E. coli; for 
Mycobacteria, this enzyme is also the major target for the anti-tubercular 
drug isoniazid, hexachlorophene and some new antibiotics, the 
diazoborines. The high degree of homology between the enoyl reductase 
of E.coli and S. aureus might have implications in a future emergence of 
triclosan-resistant staphylococci; mutations in the FabI gene of 
staphylococci can confer triclosan resistance (25). Triclosan also cause 
expression of efflux pumps common to some antibiotics. Although the 
connection between triclosan and antibiotics is clearly established, what 
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happens in the real world is still unknown, namely how triclosan affects the 
microbial flora in all environments in which it is used. The widespread of 
this biocide, could lead to environments where Pseudomonas and other 
triclosan-resistant bacteria may prevail (58). Another mechanism for 
triclosan resistance occurs through multidrug efflux pumps in E. coli 
(AcrAB) and P. aeruginosa (Mex proteins); these pumps confer both 
resistance to triclosan and antibiotics. 
 Resistance to QACs, chlorhexidine, acridines and diamidines has 
been observed in staphylococcal strains, Pseudomonas spp. and 
Enterobacteriaceace. The resistance is encoded by several multidrug 
resistance determinants, of which qacA, B, C, D and E genes are included 
(10, 18, 48). These multidrug efflux pumps can efflux a variety of 
antibiotics (trimethoprim, sulphonamids, oxacillin and aminoglycosides) 
and biocides, as well as dyes such as ethidium bromide (18). Having in 
mind that several S. aureus are methicillin-resistant (MRSA), this could 
become a problem, especially in the hospital environment. Significant 
difference between the efficacy of these agents against MRSA and 
methicillin-susceptible S. aureus (MSSA) has already been 
described/found (31). 
 
 
Enterococci are the second most frequently reported cause of 
surgical wound and nosocomial urinary tract infections and the third most 
frequently reported cause of bacteraemia (39). Little is known about their 
resistance to biocides.  
 
 
2. The genus Enterococcus 
The name “entérocoque” was first used by Thiercelin in 1899, to 
emphasize the intestinal origin of a new Gram-positive diplococcus. In 
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1906 Andrewes and Horder classified an organism isolated from a patient 
with endocarditis as Streptococcus faecalis; as it was very similar to other 
strains isolated from human intestine (19, 37). In 1933, Lancefield 
developed a serological typing system for streptococci, those of “faecal 
origin” had the group D antigen. Later Sherman proposed a classification 
scheme which separated streptococcus into four divisions: pyrogenic, 
viridians, lactic and enterococcus. The latter was used for those 
organisms able to grow at temperatures from 10 to 45 ºC and most of 
them can survive for 30 min at 60 ºC, in the presence of 6.5 % of NaCl 
and at pH 9.6 and are able to hydrolyze esculin. The enterococcus group 
included S. faecalis, S. faecium, S. bovis and S. equinus; Streptococcus 
durans was accepted either as a separate species or as a subspecies of 
S. faecium. As years passed by, more species were isolated, such as S. 
avium, S. casseliflavus and S. gallinarum. The use of nucleic acid 
relatedness helped clarified and expanded the classification of 
enterococci. In 1984, Schleifer and Kilpper-Bälz showed, by DNA-DNA 
and DNA-rRNA hybridization studies, that S. faecalis and S. faecium were 
distantly related to streptococci that they should be transfered to a new 
genus, the Enterococcus. There are more than 30 different species 
included in this genus (19, 37). 
 Enterococci are robust Gram-positive, catalase-negative, 
facultative anaerobic bacteria. They are ovoid in shape and grow in short 
chains, in pairs or single cells. They are able to grow in the presence of 40 
% of bile salts (esculin hydrolyzation) at pH from 4.6 to 9.6 (37, 39). Due 
to these characteristics, they are able to grow/survive in many different 
environments, such as humans and animal intestinal tract, sand, plants, 
water, hospitals, food industry, cheese, meat and even in insects. In the 
human and other animal intestine, the most common species found are E. 
faecalis and E. faecium. These species are also found in plants and 
invertebrates, as well as E. mundtii and E. casseliflavus (16). 
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 Since the beginning of the last century, enterococci have been 
recognized as opportunistic human pathogens. The earliest reports 
associating human diseases with enterococci were published in the 
beginning of the 20th century. Probably, many of these strains were not 
truly enterococci or could have been contaminated. As already mentioned, 
enterococci are the second most frequently cause of surgical wound and 
nosocomial urinary tract infections and the third most frequently cause of 
bacteraemia. Enterococci can also cause neonatal infections, central 
nervous system infections and intraabdominal and pelvic infections (39). 
They can also cause opportunistic infections in animals, such as 
septicaemia in chickens, bovine mastitis, endocarditis in cattle and lambs, 
and urinary-tract infections in dogs and cats (45). Enterococcal infections 
are predominantly caused by E. faecalis followed by E. faecium, E. 
durans, E. gallinarum, E. casseliflavus and E. raffinosus have also been 
responsible for infections (39).  
 In enterococcal nosocomial infections, it is hard to know if the 
microorganism comes from the patient’s own microbiota or if it was 
acquired during hospitalization. The increased number of infections 
caused by these bacteria may be a consequence of use, abuse and 
misuse of antibiotics in the last decades. Enterococci have intrinsic 
resistance to some antibiotics (such as certain -lactams, clindamicyn, 
some aminoglycosides) and acquired resistance to others (such as 
chloramphenicol, erythromycin, tetracycline, high-level aminoglycoside 
and vancomycin) (37, 39). Vancomycin resistant enterococci (VRE) are of 
great concern as this antibiotic is used as one of the last resort treatment 
for multiple antibiotic resistant enterococci. VRE strains are also a cause 
of concern in the veterinary environment, more specifically in farm animals 
(1). The use of avoparcin, a glycopeptide antibiotic, is pointed as the 
cause of appearance of VRE strains in farms. The use of that antibiotic 
has been banished in all European countries in 1997 (64). However, VRE 
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strains are still isolated from farm animals and from the environment (8, 
21, 26, 35). Enterococci also have virulence factors which are involved in 
attachment both to host cells and to extracellular matrix proteins (AS – 
aggregation substance; Esp – Enterococcal surface protein; EfaA – E. 
faecalis antigen A), in resistance to macrophages (AS; HypR – hydrogen 
peroxide regulator), in cell and tissue damage (Cyl - cytolysin; GelE – 
gelatinase; SprE – serine protease) and in immune system evasion 
(capsular polysaccharides) (39). Some of these virulence factors are 
plasmid encoded which can be transferred between enterococci. 
 Enterococci are not just “problematic” bacteria. They play an 
important role in the food industry as fermented foods and as probiotics. 
They are much used in several Southern European countries (Portugal 
included) to produce cheeses, contributing to the final organoletic 
properties of the product. Enterococci have a positive influence in the 
traditional cheese ripening and the ability to produce bacteriocins 
(especially E. faecalis and E. faecium) against some bacteria (such as 
Listeria monocytogenes, S. aureus, Clostridium botulium and Clostridium 
perfringens) (11, 12). These technological and metabolic characteristics 
turn enterococci into good starter cultures for the cheese industry. 
Enterococci can also be used as probiotic for humans and farm animals. 
However, their use as such is still controversial, due to risk of transference 
of antibiotic resistance and virulence genes to human strains (19, 20, 42, 
59). 
 
 
3. Enterococci and biocides 
The relationship between enterococci and biocides is not very well 
established. As mentioned above, enterococci can be found in different 
environments which are cleaned or disinfected with biocides. One of the 
most important environments is the clinical environment, where 
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enterococci play a critical role due to their ability to cause nosocomial 
infections. This environment is the most frequently studied and usually the 
susceptibility of enterococci is evaluated by measuring Minimal Inhibitory 
Concentration (MIC) or Minimal Bactericidal Concentration (MBC), either 
using surface carrier tests and/or suspension tests. The presence of 
enterococci in the human mouth and their ability to survive after some 
endodontic treatments is also well documented. Enterococci together with 
lactobacilli, actinomyces and streptococcus, constitute the best invaders of 
dentine and root canals. E. faecalis has been recovered from tooth canals 
when endodontic treatments failed. Several studies were performed on 
this area testing the efficacy of the most commonly used biocides in 
endodontic treatments (such as chlorhexidine, calcium hydroxide and 
sodium hypochlorite) against enterococci (3, 24, 40). Concentrations of 2 
% for chlorhexidine and 5.25 % for sodium hypochlorite were able to 
eliminate enterococci. Although some studies have been performed in 
order to understand the susceptibility of enterococci to biocides, the way 
they respond to these compounds and which mechanisms are involved 
are question that still need to be addressed. 
 
 
3.1 Thesis outline 
The main issue of this thesis was to understand the susceptibility 
of enterococci to three different biocides and if there was any relationship 
between that and resistance to vancomycin. Bacteria from this genus are 
able to grow in different environments where biocides are daily used; the 
most important are the clinical environment, the veterinary environment 
and the food industry environment. Isolates from these habitats were 
studied and characterized as well as new isolates from a never explored 
environment. Another issue was to open the door of which mechanisms 
enterococci use to respond to biocides: identification of a gene implicated 
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in the susceptibility to benzalkonium chloride and its dissemination 
through enterococci of the three different environments above mention. 
 
 E. faecalis V583 was the first enterococcal strain fully sequenced 
(41) and its EFA0010 was described as a putative multidrug resistance 
protein. The specific role of this gene was not clarified and to which drugs 
it confers “resistance” to was an open question. In chapter II it is 
discussed the role of EFA0010 in the susceptibility to benzalkonium 
chloride and the distribution of this gene in enterococci from different 
origins (clinical, veterinary and dairy isolates), as well as the susceptibility 
pattern of the same isolates to the two different biocides benzalkonium 
chloride and chlorhexidine. 
 One of the main questions concerning biocides and enterococci is 
if biocides are capable of eliminating VRE strains, which are responsible 
for many nosocomial infections, and if VRE strains are less susceptible to 
biocides than vancomycin susceptible enterococci (VSE) strains. VRE 
strains are capable of persisting on surfaces and hands, thus being easily 
transmitted and moved from one place to another (38). Therefore an 
appropriated cleaning and disinfection are required. There are some 
research works done in this field, usually comparing the MIC of VRE 
strains with VSE strains or testing the time needed to kill each with a 
certain biocide (2, 62). The conclusions are quite similar, and VRE are 
generally as susceptible to biocides as VSE. However, constant 
surveillance and more research are pointed as required. The same 
isolates discussed in chapter II were used to understand if their 
susceptibility/resistance to vancomycin was somehow related to their 
susceptibility pattern to the same biocides; this was investigated in chapter 
IV. Two isogenic strains (one VRE and the other VSE) were used in 
several assays, MIC, continuous exposure to biocides, growth curves in 
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the presence of biocides and fitness assays, in order to understand if one 
took advantage to the other under the tested conditions. 
 As previously mentioned, enterococci also play an important role in 
the veterinary environment, causing animal diseases and threating bio-
security by entering into the human food chain. Animal facilities and 
instruments are cleaned and disinfected using biocides (e.g. chlorhexidine 
and benzalkonium chloride), but few or nothing is known about how these 
compounds are affecting or selecting bacteria present in these 
environments. Chapter III presents a complete study of enterococci 
isolated from the first time from breeding pig facilities dust. The isolates 
were identified to species level, characterized for their susceptibility to 
benzalkonium chloride and chlorhexidine. The presence of VRE isolates 
and their identification and characterization was investigated, as well as 
their susceptibility to the same biocides. Understand if there was any 
association between their presence and the use of these compounds was 
also discussed.  
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Summary 
 
The aim of this work was to investigate the role of a putative small 
multidrug-resistance transporter, annotated in Enterococcus faecalis V583 
genome as EFA0010 (we will refer to this gene as qacZ), in decreased 
susceptibility to biocides. A derivative strain of V583, susceptible to 
erythromycin (V583ErmS), was complemented with pORI23 carrying qacZ 
gene (strain EF-SAVE1). MIC values for benzalkonium chloride, 
chlorhexidine and ethidium bromide were determined for the 
complemented strain and wild type. RT-PCR and ethidium bromide efflux 
assays were performed in order to fully understand the role and specificity 
of qacZ gene. The presence of qacZ in 73 enterococcal strains from 
different origins was investigated by PCR and MIC values for 
benzalkonium chloride and chlorhexidine were determined in the same 
strains. The complemented strain, EF-SAVE1, presented higher MIC 
value for benzalkonium chloride (8 g/ml) than V583ErmS (4 g/ml); for 
chlorhexidine and ethidium bromide the MIC values were the same in both 
cases, 4 g/ml and 16 g/ml respectively. Expression of qacZ was found 
to be higher in EF-SAVE1 strain and constitutive, i.e. not inducible by any 
of the three tested biocides. Overexpression of qacZ was not responsible 
for changes in ethidium bromide efflux. This gene was present in 52% of 
the enterococcal isolates studied and the MICs for benzalkonium chloride 
and chlorhexidine ranged between 2 to 8 g/ml. Tolerance to biocides was 
also determined in E. faecalis V583, the V583ErmS wild type strain, from 
which V583ErmS was derived. The role of the ermB gene in the E. 
faecalis V583 cells was discussed. 
We demonstrate the involvement of qacZ gene in tolerance towards the 
quaternary ammonium compound benzalkonium chloride, but not ethidium 
bromide. This work constitutes the first report of a biocide resistance 
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mechanism in E. faecalis, and reveals its dissemination amongst the 
genus Enterococcus.  
 
 
Introduction 
 
In the past few decades, the use of biocides as antiseptics, 
disinfectants and preservatives has been growing, not only in the hospital 
environment (sterilization of medical devices, disinfection of surfaces and 
water, skin antisepsis and preservation of various formulations) (11), but 
also in the food industry and more recently in our homes (to clean 
surfaces and hands, in oral and dental hygiene, dishwashing and more 
recently to disinfect food) (19). Introduction of biocides into clinical and 
other practice, has been suggested to contribute to selection of antibiotic-
resistant bacteria, and may lead to decrease the number of solutions to 
control bacterial load in Hospital settings, in food industry and even at 
home (6). Taken together, the need to find the mechanisms responsible 
for biocide resistance in bacteria causing severe infections, namely in 
bacteria that can be found in different environments and, therefore, 
subject to biocidal action in these same environments, is obvious and 
urgent. Enterococci are Gram-positive commensal bacteria which inhabit 
the gastrointestinal tract of humans and animals. Their robust nature 
allows them to disseminate in a variety of other habitats, namely 
fermented foods, water, soil and plants. Members of this genus have 
intrinsic and acquired resistance to several antibiotics and thus became 
the second most frequently reported cause of surgical wound and 
nosocomial urinary tract infections and the third most frequently reported 
cause of bacteraemia (12). However, and despite their relevance as 
nosocomial multiresistant pathogens, there are no tolerance mechanisms 
to biocides described so far for the genus Enterococcus. Multidrug 
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resistance transporters are responsible for both antibiotic and biocide 
resistance in bacteria. Among secondary multidrug resistance 
transporters, which use proton electrochemical gradients as the driving 
force, the small multidrug resistance (SMR) transporter family has the 
simplest organization. Among Staphylococcus isolates from both clinical 
and food sources qac genes, encoding small multidrug resistance (SMR) 
transporters, mediate resistance to quaternary ammonium compounds 
(QAC) (15, 16). pTEF1 plasmid of Enterococcus faecalis V583 carries an 
orf, EFA0010, annotated as a putative SMR transporter. In this work we 
provide evidence which supports this activity of EFA0010 and we will thus 
refer to it as qacZ gene. For practical reasons, we used E. faecalis 
V583ErmS (a derivative of E. faecalis V583, susceptible to erythromycin 
due to delection of the ermB gene (EFA0007), kindly supplied by Axel 
Hartke from Caen, France), as the plasmid used in the gene cloning 
carried resistance to erythromycin. During the course of this study, V583 
and V583ErmS were also compared in what respects biocide 
susceptibility. 
 
 
Materials and Methods 
 
Bacterial strains 
A total of 73 enterococcal isolates were randomly selected from 
the Lab collection. All these isolates were already identified to the species 
level and typed by PFGE. None of the selected 73 isolates are clones. Our 
selection focused on three different environmental sources, namely 
Portuguese milk and cheese (27 dairy isolates), nosocomial infections (30 
clinical isolates) (genito-urinary tract infections, bacteraemia/sepsis, 
catheter-associated infections), and animal infections (16 veterinary 
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isolates) (cats and dogs isolates from urinary tract and skin and soft tissue 
infections).  
E. faecalis V583, E. faecalis V583ErmS, and EF-SAVE1 (a 
derivative of V583ErmS carrying the high-copy number plasmid pSAVE1, 
constructed in the present study). 
 
Biocides 
Three different biocides were used in this study: benzalkonium 
chloride (Sigma-Aldrich) (BC), chlorhexidine (Fluka) (CHX) and ethidium 
bromide (Sigma-Aldrich) (EtBr). 
 
Susceptibility tests 
Susceptibility to benzalkonium chloride, chlorhexidine and ethidium 
bromide,  a QAC, a biguanidine and a dye, respectively, was measure by 
Mininal Inhibitory Concentration (MIC) assays (performed according to 
CLSI) (4). Strains were grown overnight in Brain Heart Infusion (BHI) broth 
from Oxoid and plated in BHI agar. Colonies were picked and incubated 
overnight in Muller-Hinton (MH) broth, also from Oxoid. The inoculum 
density was adjusted to 0.5 McFarland in fresh MH broth and diluted 
1:100. On a 96 wells microplate, 100 l of each bacterial culture diluted 
1:100 were added to 100 l solution of each compound (range from 0.25-
256 g/ml). Results were read after 24h. All incubations were performed at 
37ºC. Assays were repeated at least three times.  
 
Dissemination of qacZ gene in Enterococcus population by PCR 
The dissemination of qacZ in the 73 enterococcal isolates was 
addressed using PCR (primers qac-IF ATATTGCTTACGCAAGTTGG and 
qac-IR AGTGTGATGATCCGAATGTG); amplicon of 156 bp. The PCR 
consisted of 35 cycles of denaturation (94 ºC, 30 s), annealing (51 ºC, 30 
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s) and extension (72 ºC, 30 s). The reaction was performed using 
MasterMix (5 Prime). 
 
qacZ gene cloning 
The gene was amplified using qac - EF and qac - ER primers from 
E. faecalis V583, GAATCGGATCCATCACTTAATAAAGGAGC and 
GAATCCTGCAGATACACTAAACAAAGTGGGC, respectively; qac-EF 
has a restriction site for BamHI and qac-ER for PstI, both underlined.  The 
PCR product (480bp) obtained contains the qacZ ribosome binding site 
(RBS), but excludes the gene promoters. The reaction consisted in 35 
cycles of denaturation (94 ºC, 30 s), anneling (59 ºC, 30 s) and extension 
(68 ºC, 1 min), and was performed with Expand High FidelityPLUS PCR 
System (Roche). The amplicon and the pORI23 plasmid (14) were 
digested with BamHI and PstI enzymes (New England Biolabs) and 
ligated with T4 DNA ligase (New England Biolabs). The ligation product 
was introduced into the electrocompetent E. coli DH5cells. The 
transformants were selected on Luria-Bertani agar (LBA) (Sigma-Aldrich) 
containing 500 g/ml erythromycin (Sigma-Aldrich). Proper qacZ gene 
placement in the recombinant plasmid was (pSAVE1) confirmed by 
sequencing (Stabvida). 
 
Complementation of the qacZ in E. faecalis 
pSAVE1 was introduced into electrocompetent E. faecalis 
V583ErmS cells (prepared according to Frankenberg et al (8)). 
Transformants, named EF-SAVE1, were selected on Brain Heart Infusion 
agar (BHIA) (Oxoid) containing 500 g/ml erythromycin and confirmed by 
specific PCR using pori - F (GGATTGGATTAGTTCTTGTGG) and pori - R 
(TTGAGTGAGCTGATACCGC) primers. Size of the amplicon for “empty” 
plasmid was 408 bp and for pSAVE1 was 888 bp. The reaction consisted 
in 35 cycles of denaturation (94 ºC, 30 s), anneling (51 ºC, 30 s) and 
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extension (72 ºC, 1 min). Plasmid pORI23, without any insertion, was 
introduced into V583ErmS cells and transformants (EF-SAVE2) were used 
as a control for expression assays by RT-PCR.  
 
RNA extraction and cDNA synthesis 
 Total RNA was extracted from V583ErmS, EF-SAVE1 and EF-
SAVE2 cells. Two different assays were performed: i) strains were grown 
in BHI added of 1 g/ml BC, 2 and 4 g/ml of EtBr until OD600 0.4 was 
reached (control was performed the same way, but only in BHI); ii) strains 
were grown in BHI until a 0.4 OD600 was reached, at that time the biocides 
were added (for BC the concentrations used were 0.25, 1, 4 and 8 g/ml; 
for EtBr the concentrations used were 2 and 8 g/ml). In the first assay 
total RNA was extracted when the OD600 0.4 was reached and in the 
second assay 15 min after the addition of the biocides. Tree ml of each 
culture were used and mixed with 6 ml of RNA Protect Bacteria Reagent 
(QIAGEN); this mixture was vortexed for 5 min and left 5 min at room 
temperature. It was then centrifugated for 10 min at 3500 r.p.m. at 4 ºC 
and pellets were kept at 4ºC until RNA extraction. Total RNA was then 
extracted following the RNeasy Mini kit (QIAGEN). RNA quality and 
quantity was determined by agarose gel electrophoresis and by measuring 
the absorbance at 260 and 280 nm, respectively. Twenty-eight l of total 
RNA from each sample was treated with 3.5 l of RNase-free DNase I 
(Roche) and 3.5 l of 10x DNAse I buffer (Roche) and incubated at 37ºC 
for 1 hour. Samples were further purified using RNeasy MinElute Cleanup 
kit (Qiagen) and quantified using the NanoDrop Spectrophotometer 
(Nanodrop Technologies). Prior to PCR reactions DNA contamination of 
the RNA samples was assessed by a standard  PCR reaction with primers 
targeting a plasmidic E. faecalis V583 gene (EFA0014). The primers used 
were EFA0014-F (TTACTATTGGACAGCTTATCC) and EFA0014-R 
(TGCACTAAGGTTAATTAGGAC); the amplicon had 638 bp and the 
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reaction consisted in 35 cycles of denaturation (94 ºC, 30 s), anneling (54 
ºC, 1min) and extension (72 ºC, 2 min). The concentration of total RNA 
used for this PCR was around 500 to 1000 ng/l. 
 cDNA synthesis was performed using Transcriptor High Fidelity 
cDNA Synthesis Sample (Roche) according to the manufacturer’s 
instructions, using 1.5 µg of RNA as template (the ideal concentration is 4 
g, but due to low concentrations of RNA obtained it was not possible to 
use such quantity) and random hexamer primer. Each sample was divided 
in two, one used as control with no addition of high fidelity reverse 
transcriptase (water was used instead) and the other with addition of the 
enzyme.  
 
Reverse transcriptase PCR (RT-PCR) 
 Semi-quantitative RT-PCR was done from serial cDNA dilutions 
(1; 1:10 and 1:100), assuming that intensity of PCR product bands 
correlates to the amount of PCR product, and thus to the amount of 
template mRNA. Primers used for PCR reactions were qac-IF and qac-IR 
and the reaction was done as above mentioned for these primers. 23S 
rRNA was used as a control; primers 23S-F 
(AAAGAAATCAACCGAGATTCCCC) and 23S-R 
(AAACAAGTGCTCTACCCCCGG) with an amplicon of 694 bp and the 
reaction consisted in 35 cycles of denaturation (94 ºC, 30 s), anneling (55 
ºC, 30 s) and extension (72 ºC, 5 min). 
 
EtBr efflux assays 
EtBr efflux assays were performed according to Jonas et al. (9). 
Cells from overnight cultures of V583, V583ErmS and EF-SAVE1 were 
washed two times with 20mM HEPES buffer (Sigma-Aldrich) by 
centrifugation at 5000 rpm for 20 min and resuspended in 5 ml of the 
same buffer. After that, cells were  loaded with EtBr (final concentration 
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2.5 µM) by shaking at 37ºC and adding carbonyl cyanide 3-chloro-
phenylhydrazone (CCCP) (Sigma-Aldrich) at 40 µM (final concentration). 
Cells were incubated for one hour and after that they were washed three 
times with HEPES buffer containing EtBr (2.5 µM) and resuspended in 3 
ml of the same buffer. Cells were stored in ice until efflux was initiated by 
addition of BHI. Efflux was measured using a Cary Eclipse Fluorescence 
Spectrofluorimeter Varian every 30 s for 40 min with an excitation 
wavelength of 500 nm and an emission wavelength of 590 nm. In the 
control situation no BHI was added. All measurements were performed in 
triplicate. 
 
Protein Blast 
Protein sequence of qacZ and homologous proteins in 
Staphylococcus were obtained from NCBI database and compared using 
NCBI BLASTP (http://blast.ncbi.nlm.nih.gov/Blast.cgi). 
 
Statistical analysis  
Microsoft Office Excel 2007 was used to process the data on the 
prevalence of qacZ and MIC values obtained. The prevalence of the gene 
was compared using the Chi-squared (χ2) test to determine statistically 
significant differences. All tests were two-tailed and tested at level of 0.05 
for significance. 
 
Growth curves 
Growth curves of E. faecalis V583 and its isogenic V583ErmS 
were performed as follows: 100 l of an overnight culture were incubated 
in 10 ml of BHI; optical density (OD) at 600 nm was measure hourly during 
six hours and at 24h of incubation. 
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Results 
 
Susceptibility to biocides and presence of qacZ 
In the present work, 73 enterococcal strains from different 
environments were investigated in what concerns their susceptibility to BC 
and CHX. For all strains the MICs values for CHX and BC ranged from 2 
to 8 g/ml. In what respects CHX, the majority of the strains studied 
presented a MIC value of 4 g/ml. This value of MIC for CHX was present 
in 80 and 89 % of the clinical and dairy isolates, respectively; and in all 
veterinary isolates. Only in the clinical and dairy isolates was observed 
strains with MIC of 8 g/ml. In the case of BC, all dairy isolates presented 
a MIC of 4 g/ml; the majority of the clinical (67 %) and veterinary (69 %) 
isolates had MIC of 4 g/ml, but some strains presented MIC of 2 and 8 
g/ml. Curiously, all strains with MIC 8 g/ml for BC were E. faecium 
(Table 1). qacZ was detected in 60 % and 70 % of the strains isolated 
from clinical settings and dairy products, respectively, and was absent 
from veterinary isolates. It was detected in five different enterococcal 
species and E. faecalis and E. faecium presented very similar 
percentages of qacZ carriage, 52% and 47%, respectively. There was no 
difference in the prevalence of qacZ between different MICs values (p > 
0.05; χ2). There was a statistical difference in the prevalence of qacZ and 
the isolates origin (p < 0.05; χ2). 
V583ErmS and EF-SAVE1 MIC determinations were repeated five 
times and gave consistent and reproducible values: 4 g/ml for CHX for 
both strains, 16 g/ml for EtBr for both strains; 4 g/ml for BC in 
V583ErmS and 8 g/ml in EF-SAVE1. Although the increase in MIC value 
for BC was small (from 4 to 8 g/ml), it was consistent and reproducible.
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Table 1. MIC values for CHX and BC and the presence of qacZ gene in enterococcal strains from different species and 
environments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a 
Reclassified in 2005 as Tetragenococcus solitarius (for more information www.taxonomicoutline.org). 
 
Strains 
Nº of strains with MIC (g/ml) value
 
Benzalkonium chloride Chlorohexidine 
 2 4 8 2 4 8 
Clinical isolates qac
+ 
qac
- 
qac
+ 
qac
- 
qac
+ 
qac
- 
qac
+ 
qac
- 
qac
+ 
qac
- 
qac
+ 
qac
- 
E. faecalis 1
 
3 11 3   2 1 10 5   
E. faecium   2 3 3 2 1  3 5 1  
E. hirae 1  1    1  1    
   
Veterinary isolates qac
+ 
qac
- 
qac
+ 
qac
- 
qac
+ 
qac
- 
qac
+ 
qac
- 
qac
+ 
qac
- 
qac
+ 
qac
- 
E. faecalis  3  8      11   
E. faecium    3  1    4   
E. solitarius
a 
 1        1   
   
Dairy isolates qac
+ 
qac
- 
qac
+ 
qac
- 
qac
+ 
qac
- 
qac
+ 
qac
- 
qac
+ 
qac
- 
qac
+ 
qac
- 
E. faecalis   12 5     11 5 1  
E. faecium   3      3    
E. durans   2 3     2 2  1 
E. casseliflavus   1      1    
E. hirae   1    1      
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Reverse-transcriptase PCR 
RT-PCR was also performed in order to confirm if a higher copy 
number of EFA0010 orf in V583ErmS lead to a higher expression of this 
gene and consequently a higher MIC value for BC. qacZ was found to be  
constitutively expressed and not induced by biocides in V583ErmS strain 
and its expression seems smaller when BC at 1 and 4 g/ml and EtBr at 2 
and 8 g/ml were added at OD600 0.4. When more copies of the qacZ were 
present the expression became higher, but still not inducible. The 
presence of the pORI23 plasmid does not influence the expression of this 
gene, as can be seen in (Figure 1 a) and b)). The expression of the 23S 
rRNA gene was strong and similar for all tested conditions and strains 
(Figure 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Analysis by semi-quantitative RT-PCR for qacZ expression and 23S rRNA. 
a) biocide (when present) was added at the beginning of growth and RNA was extracted 
when OD600 0.4 was reached. 
 
 
1:1 1:10 1:100 1:1 1:10 1:100 1:1 1:10 1:100 1:1 1:10 1:100 
control BC 1g/ml EtBr 2g/ml EtBr 4g/ml 
a) 
V583ErmS 
 
 
23S 
EF-SAVE 1 
 
 
23S 
EF-SAVE 2 
 
 
23S 
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Figure 1 (cont.) . Analysis by semi-quantitative RT-PCR for qacZ expression and 23S 
rRNA.  b) biocide (when present) was added when OD600 0.4 was reached and RNA was 
extracted 15 min after addition of biocide. 
 
 
EtBr efflux assay 
In order to understand if qacZ also played a role in the efflux of 
EtBr, efflux assays were performed under the same conditions for 
V583ErmS and EF-SAVE1 cells. Figure 2 shows that in the presence of 
BHI broth, both strains were able to efflux EtBr. However, without BHI 
broth, EtBr was not pumped out of the bacterial cells. After 30 min there 
was approximately 50% of difference in fluorescence between both strains 
with BHI broth and without the medium. No decrease in fluorescence was 
seen in both strains suspended in buffer only. 
b) 
1:1 1:10 1:100 
control 
1:1 1:10 1:100 
BC 0.25g/ml 
1:1 1:10 1:100 
BC 1g/ml 
1:1 1:10 1:100 
BC 4g/ml 
1:1 1:10 1:100 
BC 8g/ml 
1:1 1:10 1:100 
EtBr 2g/ml 
1:1 1:10 1:100 
EtBr 8g/ml 
V583ErmS 
 
23S 
EF-SAVE 1 
 
23 S 
EF-SAVE 2 
 
23S 
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Figure 2. EtBr efflux assays in V583ErmS and EF-SAVE1. Efflux was initiated by the 
addition of BHI. Assays were performed in triplicate. Fluorescence units are expressed in 
% of the starting value. EtBr was used at 2.5 µM and carbonyl cyanide 3-chloro-
phenylhydrazone (CCCP) at 40 µ 
 
 
Protein blast 
From the alignment of QacZ with homologous proteins in the database 
(BLASTP, NCBI) with identities above 60%, it is possible to observe that 
QacZ has Glu-13 (E), which is conserved throughout the SMR family and 
is absolutely required for drug efflux activity (Figure 3). Putative 
transmembrane helix sequences of QacZ, a hydrophobic proteins (SOUSI 
1.1.), are represented by horizontal lines above the aligned sequences. 
Conserved aminoacid residues are indicated by bold letters. NP_816940 
is QacZ from E. faecalis V583, O87868 is QacH from Staphylococcus 
saprophyticus, NP_647561 is EtBr resistance determinant from 
Staphylococcus epidermidis, Q55339 is QacC from Staphylococcus sp. 
ST827, AAB47993 is a small multidrug resistance efflux pump from S. 
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aureus, NP_783299 is a QAC resistance protein from S. aureus, O87866 
is QacG from Staphylococcus sp. ST94. Figure 3 also shows that cysteine 
42, which is common in all Qac proteins, is substituted by a serine in 
QacZ. 
 
 
Figure 3. Alignment of QacZ (NP_816940) with homologous proteins in the database 
(BLASTP, NCBI), with identities above 60%. 
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Role of the ermB gene 
The MIC value for BC and CHX for V583 was 8 and 4 g/ml, 
respectively. The value obtained in the case o BC is higher than the 
observed for V583ErmS and equal to the one obtained for EF-SAVE1, for 
the same compound. E. faecalis V583 was also able to efflux EtBr out of 
its cells when BHI was added (Figure 4). After 30 min there was 
approximately 20% of difference in fluorescence between both strains with 
BHI broth. The efflux capacity of V583 is higher than the one observed for 
V583ErmS (and consequently than EF-SAVE1).  
 
 
 
 
 
 
Figure 4. Efflux assay in E. faecalis V583 and E. faecalis V583ErmS. 
 
The expression of qacZ in E. faecalis V583 was constitutive and 
seemed not to be induced by the presence of BC nor EtBr (Figure 5). The 
major differences found were in samples where biocides were added 
when OD600 0.4 was reached and the total RNA extracted 15 min later. 
When comparing both controls made, the expression of qacZ was lower 
15 min after reaching OD600 0.4. The lowest concentrations of BC tested 
(0.25 and 1 g/ml) may induce more activity of this gene, as well as 8 
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g/ml of EtBr. V583ErmS presented a lower expression of qacZ when 
compared with the wild-type; the levels of expression of the wild-type were 
similar to those obtained for EF-SAVE1, where multi copies of the qacZ 
were present. The amplification and expression of the 23S rRNA was 
strong and similar for all tested conditions and strains (Figure 5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Analysis by semi-quantitative RT-PCR of qacZ expression and 23S rRNA. 
a) biocide (when present) was added at the beginning of growth and RNA was extracted 
when OD600 0.4 was reached; b) biocide (when present) was added when OD600 0.4 was 
reached and RNA was extracted 15 min after addition of biocide. 
 
 
When the growth of the two strains was compared, great 
differences were observed (Figure 6). The lack of the ermB gene reduces 
the growth of V583 and the final OD reached by V583ErmS is much lower 
than the observed in the wild-type.  
b) 
V583ErmS 
 
23S 
V583 
 
23S 
1:1 1:10 1:100 1:1 1:10 1:100 1:1 1:10 1:100 
control 
1:1 1:10 1:100 
BC 0.25g/ml 
1:1 1:10 1:100 
BC 1g/ml BC 4g/ml BC 8g/ml 
1:1 1:10 1:100 
EtBr 2g/ml 
1:1 1:10 1:100 
EtBr 8g/ml 
a) 
V583ErmS 
 
23S 
V583 
 
23S 
1:1 1:10 1:100 1:1 1:10 1:100 1:1 1:10 1:100 1:1 1:10 1:100 
control BC 1g/ml EtBr 2g/ml EtBr 4g/ml 
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Figure 6. Growth curves of E. faecalis V583 and V583ErmS in BHI broth. 
 
 
Discussion 
 
Some studies have been performed in order to test enterococci 
susceptibility to biocides, namely CHX and BC. Strains from clinical 
environment (VRE and VSE) are the most common studied, as well as 
food isolates. The MICs values found for CHX ranged from 0.5 to 16 g/ml 
(2, 3, 10, 18). In the case of BC the MICs values found in literature varied 
between 0.08 and 16 g/ml (2, 7, 18). In another study (17), the authors 
examined 500 strains of food isolated Enterococcus and the MICs found 
were all < 30 g/ml. Although, the results for the isolates herein tested are 
similar to the ones described by the above mention authors and the major 
MIC value found was of 4 g/ml, qacZ was detected in 63% and 73% of 
the strains isolated from clinical settings and dairy products, respectively, 
and was absent from veterinary isolates. These values are quite high, and 
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worthy of some concern, considering that these species are 
simultaneously the most relevant in clinical settings and abundant in food 
products. No difference was found between MIC values and the presence 
of qacZ (p > 0.05; χ2), suggesting that there are other mechanisms, 
probably other multidrug efflux pumps, involved in tolerance to BC and 
CHX, as already evidenced for staphylococcal isolates (5). However, 
when comparing the presence of the qacZ gene and source of isolates, 
statistical difference was found (p < 0.05; χ2), as no veterinary isolate 
presented this gene. It is not possible to rule out the hypothesis that qacZ 
is less disseminated in the veterinary clinical environment. A search with 
more strains is advisable to confirm this finding. The increase in MIC value 
for BC observed for EF-SAVE1 when compared to V583ErmS was small 
(from 4 to 8 g/ml). This was a consistent and reproducible result that 
evidences the involvement of qacZ in decreased susceptibility to QAC, 
and not to CHX nor to EtBr (as the MIC values for these compounds 
remain the same).  
RT-PCR confirmed a higher expression of qacZ in strain EF-
SAVE1 and consequently a higher MIC value for BC, and that qacZ 
expression was not induced by the presence of BC and EtBr. The latest 
compound is highly fluorescent when it is bound to DNA inside the cell. 
When the EtBr is effluxed from the cell by way of an efflux pump, the 
fluorescence will decrease and this can be measured with a fluorescence 
spectrophotometer. The fluorescence of EtBr was used to measure the 
efflux of the compound from bacterial cells. The bacterial cells were 
starved and loaded with EtBr after dissipation of the membrane potential 
with the protonophore CCCP. Without an energy source the efflux pumps 
cannot function; therefore, the EtBr cannot be effluxed and the cells 
become loaded. Efflux of EtBr was initiated by the addition of a carbon 
source (BHI broth) that allows reconstitution of the membrane potential. 
V583ErmS and EF-SAVE1 have the same EtBr efflux ability, consistent 
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with QacZ being unable to provide resistance to EtBr. Figure 3 shows that 
cysteine 42, which is common in all Qac proteins, is substituted by a 
serine in QacZ. Paulsen et al (13) demonstrated that substitution C42S 
leads to a huge decrease in ability of QacC to provide resistance to EtBr 
(13). S42 in QacZ can thus provide us with a reason for its specificity to 
BC. 
From data obtained using the wild-type strain, it is possible to 
understand that the ermB gene may play a role that goes further than 
resistance to erythromycin.   
There were some differences detected between the wild-type 
strain E. faecalis V583 and its isogenic without the ermB gene. This gene 
codes for a ribosomal RNA adenine dimethylase family protein. The rRNA 
methylation causes conformational changes in the P site of the rRNA and 
prevention of macrolide binding (1). The lack of this gene seems to affect 
the cell in a lot of processes besides less resistance to erythromycin: 
growth is affected, the expression of qacZ and efflux of EtBr are smaller. 
The MIC values for CHX and EtBr were the same for V583ErmS and the 
wild type, as well as for EF-SAVE. The exception was for BC; wild-type 
presented a MIC of 8 g/ml for this compound, while V583ErmS had a 
lower MIC (4 g/ml). When more copies of the qacZ gene were introduced 
in V583ErmS, the phenotype was reverted. This demonstrates that qacZ 
is involved in the susceptibility to BC and its expression is affected by the 
presence/absence of ermB gene. Some other genes maybe down 
regulated by the absence of this methylase and/or it may play a role in the 
V583 cell that goes further than just erythromycin resistance. Future work 
must be done in order to address these questions. 
 
In summary, we provide evidence for the role of QacZ in tolerance 
to BC in enterococci. The wide spread and high prevalence of qacZ 
among the Enterococcus genus, bacteria presenting a dual role and a 
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transversal environmental dissemination, is a cause of concern and urges 
future studies.  
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Summary 
 
Bio-security measures in pig facilities include disinfection with biocides to 
avoid the dissemination of opportunistic pathogenic bacteria, namely 
enterococci and vancomycin-resistant enterococci (VRE). In order to 
evaluate if the use of biocides is selecting for less tolerant enterococci and 
for VRE, we sampled dust from 171 breeding pig facilities, representative 
of the total of the Portuguese pig population. A total of 191 enterococcal 
isolates were recovered with (n=41) or without (n=150) vancomycin 
selection and screened for susceptibility towards benzalkonium chloride 
(BC) and chlorhexidine (CHX). Enterococcus faecalis and Enterococcus 
hirae were the most prevalent species detected. Ten isolates with high-
level vancomycin-resistance were found. Amongst these, four 
Enterococcus faecium carrying vanA gene were detected and by Multi 
Locus Sequence Typing (MLST) determined to have four different 
sequence types (139, 522, 523 and 524). Based on the MLST these E. 
faecium isolates were found to be closely related to pig and human 
isolates from European countries and Brazil. Minimal Inhibitory 
Concentration values for CHX and BC were 8g/ml and 4 g/ml, 
respectively. No association was found between less susceptibility to 
biocides and vancomycin-resistance, suggesting that biocides are not 
selecting for vancomycin-resistant enterococci. Overall, this work reports 
the presence of enterococci and VRE in dust from pig facilities. We also 
evidence that the vanA E. faecium found are genetically related to strains 
found in humans, demonstrating that the transmission of VRE into humans 
may occur through inhalation of dust. This work suggests constant 
surveillance in order to avoid animal and human colonization with VRE.  
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Introduction 
 
Enterococci are natural inhabitants of the gastro-intestinal tract of 
humans and other animals. They also rank now as leading nosocomial 
infectious agents worldwide, likely as a consequence of the increased use 
of antibiotics both in hospitals and in agriculture, as animal growth 
promoters. Enterococci constitute the third most prevalent pathogen 
isolated from bloodstream infections, and represent the most frequent 
cause of surgical-site infections in intensive care units (35). A new wave of 
concern about enterococcal infections comes from the dissemination of 
vancomycin resistance amongst enterococcal nosocomial isolates. This 
impairs the use of vancomycin to treat infections caused by multi-resistant 
Gram-positive bacteria. In Europe, vancomycin-resistant enterococci 
(VRE) are disseminated also outside the nosocomial environment. The 
use of growth-promoting drugs in food animals has caused an increase of 
antibiotic resistance in enterococci of animal origin. These bacteria are 
widely accepted as an indicator for the detection of the prevalence of 
resistance due to the use of growth-promoting antimicrobial agents (7). 
Several studies have described the correlation between the use of 
avoparcin as a growth promoter in farm animals and the occurrence of 
VRE (42). Although avoparcin has been banned in all European countries 
since 1997, the presence of VRE is still detected and therefore these 
bacteria may enter the food chain.  
Thus, it is important to keep animal facilities under constant 
surveillance for VRE assessment. Enterococci are able to survive outside 
their hosts, and are thus found viable in soil, water and surfaces (16, 18). 
These environments can constitute dissemination vehicles for resistance 
mechanisms and resistant enterococcal strains between man and 
animals. Dust is also an important transmission vehicle for 
microorganisms, as they can easily go from one place to another and can 
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also be inhaled by humans or animals, thus transmitting virulence and 
antibiotic resistance genes that can be present in those microorganisms. A 
proper cleaning and disinfection of the animal facilities is thus an important 
way to avoid animal infections. Biocides are usually used to (i) clean and 
disinfect the farm building, (ii) create barriers (ex.: foot dips), (iii) disinfect 
vehicles and materials during outbreaks of infectious diseases, (iv) direct 
application to animal surfaces and (v) preservation of specific products 
(36). For that, the use of biocides, such as biguanides, quaternary 
ammonium compounds (QACs), triclosan and others, has been increasing 
in the last few decades. Chlorhexidine (CHX) is usually used for cleansing 
wounds, skin, instruments and equipment. It is also used on teat dips and 
sprays in mastitis control (11). Benzalkonium chloride (BC) is usually used 
for cleansing and disinfection of stablings and animal transports, but can 
also be used as an injectable formulation, eye lotion and dermal spray 
(10). The increased use of biocides has raised the question if they could 
be selecting for antibiotic resistant bacteria (5). 
In this study, enterococcal strains were, for the first time, isolated 
from dust samples collected from Portuguese breeding pig facilities. Their 
susceptibility to CHX and BC, a biguanide and a QAC respectively, was 
studied. We also investigated the presence of VRE on these samples and 
their susceptibility to the same biocides. Nasal mucosa of some veterinary 
swine practitioners was also searched for the presence of these bacteria 
and its characterization. 
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Materials and Methods 
 
Sample collection 
Dust samples were collected in 171 Portuguese breeding pig 
facilities. The collection was performed during October, November and 
December 2008. The survey was carried out on holdings harboring at 
least 80 % of the breeding pig population in Portugal. Preferentially 
holdings having 50 breeding pigs or more were sampled. Smaller holdings 
with less than 50 breeding pigs were also sampled because 80 % of the 
national herd of breeding pigs did not contain holdings having 50 breeding 
pigs or more. In each selected breeding herd and production herd taking 
into account an annual expected prevalence of 50 % of enterococci, five 
dust samples were gathered using five dry sterile swabs of about 500 cm2 
each (Sodibox) from five of the 10 pens selected for sampling. These five 
pens were chosen in a way that breeding pigs in different production 
stages were included (including gestation and farrowing). For each pen 
dorsal surfaces of pen partition walls were swabbed. In case there was not 
enough dust present, then ventilator ducts, etc. were sampled in addition. 
After use, the soiled swabs were placed in a sterile plastic bag. Samples 
were kept at room temperature during transportation and at ± 4ºC during 
storage. The samples were sent to the laboratory as quickly as possible 
and reached the laboratory no later than 10 days after sampling. There, 
the European base-line study for methicillin-resistant Staphylococcus 
aureus was being done according to the European Comission (EC) 
Decision 2008/55/EC, and enterococci were isolated from the enrichment 
media used for the EC study (9). 
Enterococci were also isolated from the nose of six veterinary 
doctors of three different pig facilities, using a cotton swab that was placed 
into modified Amies’ transport medium (Deltalab). 
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Isolation of enterococci and putative VRE  
A sterile plastic bag containing a pool with the five dust swabs from 
each holding was filled with 100 ml of Mueller-Hinton broth (MH) (Oxoid) 
supplemented with 6.5 % NaCl and incubated at 37 °C for 16-20 h. The 
cotton swabs from nasal sampling were pooled into 10 ml of the same 
medium and incubated under the same conditions. 100 l of each culture 
were spread onto Enterococcosel agar (Becton) and another 100 l onto 
Enterococcosel agar supplemented with 16 g/ml of vancomycin. Both 
plates were incubated for 48 hours at 37ºC. From each plate one single 
colony (small, translucent with brownish-black to black zones) was 
selected, streaked onto Brain Heart Infusion (BHI) (Oxoid) agar plate and 
incubated for 24 hours at 37ºC. If pure, the culture was gathered with a 
sterile cotton swab and stored in cryovials containing glycerol with BHI 
(20% v/v) at -80ºC for further identification and characterization. 
 
Identification and characterization of isolates 
Identification to the species level was performed by multiplex PCR 
(Biometra T3000 Thermocycler) according to Danish Integrated 
Antimicrobial resistance Monitoring and Research Programme (DANMAP) 
(13) targeting specific genes (Table 1). Each multiplex PCR contained: 2 
l of each primer (10 pmol), 9 l of MgCl2 (25mM), 5 l of 10x Taq Buffer 
(Fermentas), and 0.5 l of Taq DNAPolimerase (5U/l) (Fermentas). 
Isolates, for which the multiplex PCR was unable to identify the species, 
were further characterized using other species specific primers (Table 1). 
For isolates from plates with vancomycin, detection of vanA and vanB 
genes was performed by PCR (Table1). 
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Susceptibility testing 
Susceptibility to biocides was assessed for all isolates in this study. 
Minimal inhibitory concentration (MIC) for BC (Sigma-Aldrich) and CHX 
(Fluka) were determined by microdilution according to Clinical and 
Laboratory Standards Institute (CLSI) (8). Isolates were grown overnight in 
BHI broth (Oxoid) and plated onto BHI agar. Colonies were picked and 
incubated overnight in Muller-Hinton (MH) broth (Oxoid). The inoculum 
density was adjusted to 0.5 McFarland in fresh MH broth and diluted 
1:100. On a 96 wells microplate, 100 l of each bacterial culture diluted 
1:100 were added to 100 l solution of each compound (range from 0.25-
256 g/ml). Results were read after 24h. Assays were repeated at least 
three times. MIC was the lowest concentration of biocide at which the 
tested microorganism did not show visible growth. All incubations were 
performed at 37ºC. All vancomycin-resistant isolates were assayed using 
E-test (Biomérieux), according to manufacturer instruction, for vancomycin 
MIC determination. Isolates with high-level vancomycin resistance were 
also assayed for susceptibility to teicoplanin by E-test (Biomérieux). 
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Table 1: Primers used for identification of enterococcal isolates and of vancomycin resistance genotype. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Target 
gene 
Species Type strain 
Amplicon 
size (bp) 
Nucleotide sequence (5’ – 3’) 
Annealing  
temperature 
(ºC) /time (s) 
Ref. 
ddlE. faecalis  E. faecalis 
DSMZ 
20478 
550 
Fwd ATC AAG TAC AGT TAG TCT T 
55/ 30 (13) 
Rev ACG ATT CAA AGC TAA CTG 
ddlE. faecium E. faecium 
DSMZ 
20477 
941 
Fwd CCA AGG CTT CTT AGA GA 
Rev CAT CGT GTA AGC TAA CTT C 
vanC1 E. gallinarum 
DSMZ 
20628 
329 
Fwd TCT CCA GAA TAC TCA GTG T 
Rev ACA TGG CAA CCA ACA TAA 
vanC2/3 E. casseliflavus 
DSMZ 
20680 
448 
Fwd CCT CAA AAG GGA TCA CTA A 
Rev TCT TGA TAG GAT AAG CCG A 
16S 
Enterococcus 
spp. 
 708 
Fwd GGT TTC TTA AGT CTG ATG T 
Rev GAA GCT TTA AGA GAT TAG C 
 
mur-2 E. hirae 
DSMZ 
20160 
521 
Fwd CGT CAG TAC CCT TCT TTT GCA GAG TC 
60/15 (3) 
Rev GCA TTA TTA CCA GTG TTA GTG GTT G 
mur-2ed E. durans 
DSMZ 
20633 
177 
Fwd AAC AGC TTA CTT GAC TGG ACG C 
55/15 (3) 
Rev GTA TTG GCG CTA CTA CCC GTA TC 
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Table 1: Continued. 
 
Target 
gene 
Species Type strain 
Amplicon 
size (bp) 
Nucleotide sequence (5’ – 3’) 
Annealing  
temperature 
(ºC) /time (s) 
Ref. 
sodA E. raffinosus 
DSMZ 
5633 
287 
Fwd GTC ACG AAC TTG AAT GAA GTT 
50/30 (24) 
Rev AAT GGG CTA TCT TGA TTC GCG 
sodA E. dispar 
DSMZ 
6630 
284 
Fwd GAA CTA GCA GAA AAA AGT GTG 
45/15 (24) 
Rev GAT AAT TTA CCG TTA TTT ACC 
sodA E. mundtii 
DSMZ 
4838 
98 
Fwd CAG ACA TGG ATG CTA TTC CAT CT 
60/15 (24) 
Rev GCC ATG ATT TTC CAG AAG AAT 
sodA E. flavescens 
DSMZ 
7370 
284 
Fwd GAA TTA GGT GAA AAA AAG TT 
45/30 (24) 
Rev GCT AGT TTA CCG TCT TTA ACG 
 
vanA E. faecium 
BM 
4147 
731 
Fwd GGA AAA CGA CAA TTG CTA TT 
55/30 (13) 
Rev GTA CAA TGC GGC CGT TA 
vanB E. faecalis V583 175 
Fwd ATC GGC CTA CAT TCT TAC A 
55/30 (13) 
Rev AGC GTT TAG TTC TTC CGT 
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Multilocus Sequence Typing (MLST) 
Genetic relatedness of E. faecium vancomycin resistant isolates 
was determined by MLST. Internal fragments of seven housekeeping 
genes were amplified by PCR with the set of primers and conditions 
described by Holam et al. (22). Briefly, PCR conditions for all 
amplification reactions were as follows: initial denaturation at 94ºC for 3 
min; 35 cycles at 94ºC for 30 s, 50ºC for 30s and 72ºC for 30s; and 
extension at 72ºC for 5 min. Each PCR was performed using 8 l 2x 
DyNazyme MasterMix (Finnzymes) in a 20 l reaction. Sequencing of 
amplicons was performed by Applied Biosystems 3730xl DNA Analyzer 
using the Sanger method with BidDye Terminator V3.1 reagent (Applied 
Biosystems) (StabVida) and sequence types were determined and 
compared using the MLST database for E. faecium 
(http://efaecium.mlst.net/). A dendrogram was created with data 
retrieved by the allelic profile query from the MLST database. 
 
 
Results 
 
Identification of enterococcal isolates and of putative VRE 
A total of 171 Portuguese pig facilities were sampled in this study 
and Enterococcus were isolated and identified in 88% (150 facilities) of 
those (Figure 1). These 171 pig facilities are representative of the pig 
breeder’s population of the national territory. The most prevalent species 
found was E. faecalis, followed by E. hirae (Table 2). Twenty-five isolates 
were not identified to the species level, despite attempts using primers for 
the species mentioned in Table 1. 
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Figure 1: Identification by PCR of some of the isolated enterococci. Lines: 1 – NZY 
DNA ladder I in bp (NZYTech); 2, 8, 9 and 11 – Enterococcus spp.; 3 to 7 – E. faecalis; 10 
– E. faecium; 12 – E. casseliflavus. 
 
We were able to recover isolates from plates containing 
vancomycin from 41 pig facilities of the 171 sampled. Among these 41 
isolates, the most common species were E. faecium and E. casseliflavus, 
followed by E. hirae (Table 2). These putative VRE isolates were further 
analyzed using E-test for vancomycin MIC determination. Eleven out of 
the forty one had MIC values classified as susceptible (≤ 4g/ml). Among 
these, three were identified as E. hirae, three as E. faecalis and five as E. 
faecium. Twenty putative VRE strains were classified as intermediate 
(low-level resistance) to vancomycin (6-24 g/ml). In this group, ten were 
identified as E. casseliflavus, five as E. gallinarum, four as E. faecalis and 
one as E. faecium. Ten enterococcal strains presented high-level 
resistance to vancomycin (MIC > 256 g/ml), four were E. faecium and six 
were E. hirae. From these ten, two E. faecium were resistant also to 
teicoplanin, as well as one E. hirae. The vanA gene was detected in all E. 
faecium with high-level resistance to vancomycin; the vanB gene was 
present in two of the six high-level vancomycin resistant E. hirae and in 
one E. gallinarum with low-level resistance to vancomycin (MIC 16 g/ml).  
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Table 2: Enterococcal isolates (n=150) and putative VRE isolates (n=41). 
Species Total Percentage (%) 
Enterococcal isolates (n=150) 
E. faecalis 53 35 
E. hirae 39 26 
E. faecium 22 15 
E. casseliflavus 
 
7 5 
E. gallinarum 
 
2 1 
E. rafinosus 
 
2 1 
Enterococcus spp.
a
 25 17 
Putative VRE isolates (n=41) 
E. faecium 10 24 
E. casseliflavus 10 24 
E. hirae 9 22 
E. faecalis 
 
7 17 
E. gallinarum 5 13 
 
a
 These isolates are not from none of the species mention in Table 1. 
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Multilocus sequence typing 
MLST typing was performed for the four E. faecium found to be 
high-level resistant to vancomycin (VREF), all carrying vanA and the 
seven house-keeping genes. 
 
Results obtained in the MLST analyses are presented in Table 3.  
 
Table 3: MLST results for the VREF isolates. 
Strain 
name 
Allele number for gene loci: ST 
atpA ddl gdh purK gyd pstS adK 
T2706 57
a
 2 1 3 1 1 5 522
b
 
E1777 3 5 1 3 1 1 5 139 
F2010 9 5 12 3 1 20 1 523
b 
C2511 4 5 12 3 1 20 1 524
b
 
a
 new allele; 
b
 new ST 
A new allele for atpA gene was found for strain E. faecium T2706. Three 
new STs were described, 522, 523 and 524. We found ST139 (strain 
E1777), which was already found in a pig from Belgium (15). The closest 
ST to the new ST 522 is 184, detected in a strain isolated from a pig, also 
in Belgium (A0047). These two STs differ only in the atpA allele. For ST 
523 and 524 we built a dendogram, presented in Figure 1. The closest ST 
to both is 153 (strain E0684). The closest strain to the group formed by ST 
523 and ST 153 is A1769, isolated in Felgueiras, Portugal, from a pig 
(Figure 2 a)) (19). There are three other STs related with the group formed 
by ST 524 and ST 153, ST 97, ST 183 and ST 272, all detected only in 
human isolates. ST 183 was detected in one strain, while the other two 
STs were found in 3 strains each (Figure 2 b)). 
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a
) 
b) 
Figure 2: Dendogram for VREF ST 523 (a) and ST 524 (b). Both strains inside 
rectangular square.  
a) Strain E0684: isolated from a pig in Spain. Differs from F2010 in atpA allele; Strain 
A1769: isolated from a pig in Portugal. Differs from F2010 in gdh allele and of E0684 in 
gdh and atpA alleles. 
b) Strain E0684: isolated from a pig in Spain. Differs from C2511 in atpA allele; Strain 
E4178: isolated from non-hospitalized person in France. Differs from C2511 in gdh allele 
and of E0684 in gdh and atpA alleles; Strains E3766 and E1999: isolated from hospitalized 
patient in Netherands and Berlin, respectively. Both differ from C2511 in gdh allele and of 
E0684 in gdh and atpA alleles; Strain A0046: isolated from non-hospitalized person in 
Belgium; differs from C2511, E4178. E3766 and E1999 in gdh allele and from E0684 in 
gdh and atpA alleles; Strains A1496 and E1695: isolated from hospitalized patient in 
Germany and Brazil, respectively; Differ from C2511 in gdh allele, as well as, from all the 
other above mention, with the exception of E0684; Strain E1037: isolated from non-
hospitalized person in Netherlands; differs from the others in the same way as A1496 and 
E1995. 
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Susceptibility to biocides 
All isolates from dust samples were tested for their susceptibility to 
two chemically different biocides, BC and CHX. For BC, MIC values had a 
maximum of 4 g/ml and for CHX of 8 g/ml. Results are presented in 
Figure 3 for enterococcal isolates (n=150) and in Figure 4 for putative 
VRE isolates (n=41). In the enterococcal isolates sampled, MIC of 4 g/ml 
was the highest and the most common value found for BC. 87% and 82% 
of the E. faecalis and E. faecium, respectively, presented this MIC value 
for BC, while it was only registered in 28% of the E. hirae. In this species, 
the most common MIC value for BC was 2 g/ml, which was present in 
64% of E. hirae. In the same isolates (n=150), the highest MIC value 
obtained for CHX was 8 g/ml and was only detected in E. faecalis. MIC of 
4 g/ml was the most common value for this compound; it was detected in 
78%, 28% and 18% of E. faecalis, E. hirae and E. faecium isolates, 
respectively. In the last two species, E. hirae and E. faecium, the most 
common MIC value for CHX was 1 g/ml (in 41% of this specie isolates) 
and 2 g/ml (in 46% of this specie isolates), respectively. 
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Figure 3: Distribution of MIC values (in g/ml) for BC (top) and CHX (bottom), by 
species of enterococcal isolates from dust samples (n=150). 
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Figure 4: Distribution of MIC values (in g/ml) for BC (top) and CHX (bottom), by 
species of putative VRE isolates (n=41). 
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In Table 4 we present the association between the MIC values for 
both biocides and vancomycin for all VRE isolates. The majority of VRE 
isolates presented low-level resistance to vancomycin, and it was in this 
group that the highest MIC for CHX (8 g/ml) was detected. Half of the 
high-level resistant isolates had a MIC of 2 g/ml for BC and the other half 
4 g/ml.  
 
Table 4. Distribution of the MIC values (in g/ml) for BC, CHX and Vancomycin in 
putative VRE isolates (n=41).  
 
 
a
 None of the isolates had MIC value of 32, 64 or 128 g/ml for vancomycin. hi – E. hirae; 
ca – E. casseliflavus; ga – E. gallinarum; fl – E. faecalis; fc – E. faecium. VA – vancomycin: 
CHX – chlorhexidine; BC – benzalkonium chloride. 
 
MIC 
for 
VA
a
 
Species distribution according to CHX MIC 
MIC for 
BC
 
 0.5 1 2 4 8  
2 
 hi  hi  2 
     4 
3 
     2 
  hi   4 
4 
   fl  2 
  fc (n=3)  fl (n=2); fc (n=2)  4 
6 
   fl  2 
     4 
8 
     2 
   fl (n=2) fl 4 
12 
 ca ca ga  2 
   ca (n=2) ca 4 
16 
  ga ca  2 
  ca ca (n=2); fc; ga  4 
24 
ca  ga (2)   2 
     4 
> 256 
fc (n=2) fc  hi (n=2)  2 
 hi (n=2) hi hi; fc  4 
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In these isolates the MIC values for CHX are quite disperse (from 0.5 to 4 
g/ml), and none of them had MIC of 8 g/ml. MIC of 8 g/ml for CHX was 
only present in two strains, one E. faecalis and one E. casseliflavus, both 
low-level resistant to vancomycin.  
All six swine veterinarian practitioners tested positive for the 
presence of enterococci. E. faecalis was identified in three of the six 
samples, E. faecium in two of them and E. hirae in one. The MICs for BC 
ranged between 2 and 4 g/ml. For CHX all strains presented a MIC of 4 
g/ml, with the exception of one E. faecium (0.5 g/ml). There were no 
isolates recovered from selective plates with vancomycin. 
 
 
Discussion 
 
Pig facilities as well as pigs, play an important role in transmission 
of enterococci, from animals to humans, through the food chain (20). It is 
thus reasonable to assume that dust from pig facilities are partners in this 
transmission. However, dust has never been sampled for screening the 
presence of enterococci or VRE. This is the first step to evaluate its role in 
transmission of enterococci between food and humans. Assuming that 
dust is cleaned using biocides, it is also logical to ask if the strains 
recovered from dust are more resistant to biocides. In order to better 
understand these two issues, we sampled 171 pig facilities, a 
representative sample of Portuguese breading pig facilities. Our results 
will thus give an idea of the diversity of enterococci in this environment in 
Portugal. Two groups of isolates were studied: the total enterococcal 
isolates (n=150) and the putative VRE (n=41). E. faecalis was the most 
frequent species in the larger group (n=150) and E. faecium the most 
frequent among putative VRE isolates (n=41). Some work has been 
published concerning the presence of enterococci in pigs and related 
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environments. These works have focused on feces, manure, meat, soil 
and waste water. The most common species found were E. faecalis, E. 
faecium, E. durans, E. hirae, E. gallinarum, E. casseliflavus, E. solitarus, 
E. avium and E. mundtii (6, 25-28, 30, 33, 38). In general, we can say that 
the species found in dust are the same found in other environments 
related with pigs and pig facilities. 
Our protocol for isolation of putative VRE recovered 41 isolates 
from the 171 pig facilities sampled. After performing the E-test for this 
antibiotic, 30 of these isolates were confirmed as VRE. The prevalence of 
VRE present in dust samples of Portuguese breeding pig facilities is thus 
17.5 %. However, if we took in account all the isolates that grew in plates 
with vancomycin, the prevalence of VRE would be 24 %. Despite the 6.5 
% difference in the prevalence, we can say that the method used allows 
isolation of low-level vancomycin resistant species. There is no data 
available concerning VRE prevalence in the same type of samples and 
thus we cannot compare them. The only reports on the prevalence of VRE 
in similar environments are from superficial waters, solid waste, air and 
others (26%) (32), and from environmental swabs from broiler farms (20). 
The reported prevalence of VRE in pigs and pig environments is highly 
variable. In pig feces, values ranges from 85 % in a Greek study (29) to 
7.1 % in a Spanish publication (21); 3.5 % in samples from large intestine 
after incision with a scalpel in a European study (14); and 17 %, 2 % and 6 
% of VREF prevalence in Denmark, Spain and Sweden, respectively (1). 
In a recent publication, enterococci were screened in several animal and 
human feces and VRE were only recovered in pig samples (in six samples 
out of 55) (17). VRE prevalence of 8.5 and 12.5 % in fecal sample of pig 
farmers and non-farmers respectively, was described by Aubry-Damon et 
al. (4); in our study, no VRE were detected in veterinary medical doctors, 
although a direct comparison, as our samples were from nasal mucosa, is 
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not possible. The relevant finding is that VRE can be found in dust from 
pig facilities, with a high frequency – this is relevant and worrisome. 
Resistance to teicoplanin was also investigated for all high-level 
vancomycin resistant isolates. The vanA genotype is described to confer 
resistance to teicoplanin, while the vanB genotype does not (12). In our 
work, three isolates presented resistance to both vancomycin and 
teicoplanin and two of them carry vanA (E. faecium E1777 and F2010). All 
the other isolates showing high-level resistance to vancomycin (including 
two E. faecium carrying vanA) were susceptible to teicoplanin. This has 
also been reported in other studies: one E. faecium of fecal swine origin 
(carrying vanA) (34); one E. faecails and one E. faecium, both hospital 
isolates and carrying the vanA gene (31). Isolates with the vanA genotype, 
but susceptible to teicoplanin, corresponding to a VanB phenotype, have 
also been reported by others (43); as well as, the other way around, 
strains of vanB genotype may have co-resistance to vancomycin and 
teicoplanin (VanA phenotype) (41). Therefore, for unusual isolates, such 
as the ones from this study, phenotype cannot be inferred from the 
genotype. Two, out of six E. hirae high-level resistant to vancomycin, 
carried the vanB gene. Curiously, in Spanish fecal samples of pigs, an E. 
hirae carrying the vanB2 gene was found, although this had not high-level 
resistance to vancomycin (40). One E. gallinarum carried the vanB gene 
and presented a MIC of 16 g/ml to vancomycin. This is not the first report 
of an E. gallinarum carrying vanB. Such a case has been reported 
previously by Ishii et al. (23), but from pus obtained from a periproctal 
abscess on a patient with acute myeloid leukemia. The vancomycin MIC 
of this strain was also low (6.25 g/ml).  
MLST data from VREF from our samples also revealed relevant 
results. Three new STs were found (ST 522, 523 and 524) and another 
that was already described (ST 139) (15). Sequence types were 
compared with the ones already reported in the E. faecium MLST 
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database. As expected, the closest STs to the new ones are all of animal 
origin (source: pig). This finding means that animals may be infecting its 
environment and/or that dust may be carrying enterococci that are 
colonizing the animals. It is also interesting to notice that some of the STs 
found in this study are closely related with STs detected in strains isolated 
from humans (hospitalized and community) in six different countries, from 
Europe and South America. This result strongly suggests that these 
bacteria can also be transmitted from humans to animals and vice-versa.  
A proper cleaning and disinfection of any animal facility plays an 
important role in protecting animals and workers. Benzalkonium chloride 
and chlorhexidine are usually used in the farm environment. No resistance 
to any of these biocides was detected in the 150 enterococcal isolates as 
the highest MIC values were 4 g/ml for BC and 8 g/ml for CHX. There 
are several studies concerning resistance to biocides in clinical 
enterococcal isolates, but very few reports regarding veterinary isolates. 
The results herein presented are very similar to those reported by 
Aarestrup and Hasman (2). These authors studied susceptibility to BC and 
CHX in 52 E. faecalis and 78 E. faecium of animal origin (including pigs) 
from the Danish Institute for Food and Veterinary Research collection. In 
the case of BC, the authors obtained MIC values from 2 to 8 g/ml and 2 
to 16 g/ml for E. faecalis and E. faecium, respectively. In that study, and 
in contrast with ours, the MIC values were higher and 88 % of E. faecalis 
had MIC of 8 mg/ml; while 27 % and 49 % of E. faecium had MIC of 16 
and 8 g/ml, respectively. For CHX, these authors obtained MIC values 
between 0.5 and 8 g/ml, for both species. Curiously, the majority of the 
E. faecalis (88 %) had MIC of 8 g/ml. The greater part of E. faecium (60 
%) had MIC of 4 g/ml for CHX. In another research work (37), 500 
Enterococcus spp. from animal origin (broilers, cattle and pig) presented 
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MIC to BC below 30 g/ml. In clinical isolates the MICs found for CHX and 
BC are quite similar to those obtained in our study (39).  
For the putative VRE isolates (n=41), the MIC values for BC and 
CHX were in the same range of those obtained for the Enterococcus 
isolates (n=150). For BC all strains presented MIC of 2 or 4 g/ml, with no 
special incidence in any type of enterococcal strain. Regarding CHX, the 
MIC values ranged between 0.5 and 8 g/ml; only two strains had MIC of 
8 g/ml, one E. faecium and one E. casseliflavus. From these results, 
there seems to be no association between VRE and less susceptibility to a 
biocide, nor evidence that the frequent use of a biocide may be selecting 
VRE strains. 
Dust from pig facilities is an important vehicle for dissemination of 
bacteria, as they can be inhaled by workers and animals and go from a 
place to another. Good practices of cleaning and disinfection may be a 
good way to eliminate the majority of these microorganisms. In this study, 
we tried to understand if the use of biocides was being efficient in the 
Portuguese breeding pig facilities and if it was selecting bacteria (in our 
case Enterococcus) resistant to this type of compounds and/or 
vancomycin. For that we used a new methodology which allows the 
isolation of different enterococcal strains from samples with high diversity 
of microorganisms (dust), and is also a good approach for the isolation of 
VRE strains, as low-level resistant enterococci were also selected. The 
prevalence of VRE found (17.5 %) is still a cause of concern, as animals 
maybe carrying resistance genes into the food chain. The ban of 
avoparcin usage in the pig industry in the European Union is still recent 
and may reflect the high VRE prevalence. In the case of biocides, the MIC 
values distribution is similar to other environments, which is good for the 
farm bio-security. There seems to be no correlation between the use of 
these compounds and VRE presence. Enterococci isolated from 
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Portuguese breeding pig facilities: a case of concern? Above all, it is a 
reason for implementing constant surveillance. 
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Vancomycin resistance in enterococci 
does not fit and is not selected under 
biocide challenge. 
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Summary 
 
Enterococci can be found in many different environments, such as 
hospitals, veterinary facilities and food industry. These environments are 
cleaned and disinfected every day with biocides. Their use has been rising 
in the past decades and little is known about how enterococci respond to 
these chemical agents. The presence of vancomycin-resistance 
enterococci (VRE) in the above mentioned environments constitutes a 
cause of concern. VRE ability to tolerate biocides, when compared to 
vancomycin-susceptible enterococci (VSE), has not been well understood 
or evaluated. In order to address the questions are VRE strains more 
tolerant or have more survival advantages in the presence of three 
different biocides (benzalkonium chloride, chlorhexidine and triclosan) 
than VSE? Tolerance to these biocidal compounds was compared in an 
enterococcal population from clinical and veterinary environments and 
from dairy products and no correlation was found between the MIC value 
for the biocide and susceptibility to vancomycin. To address the second 
question, we used two isogenic strains (one VRE and one VSE). Strains 
were grown alone or together, and growth rates in the presence of 
biocides were determined, as well as relative fitness. When growing alone, 
growth was significantly affected by the highest concentration of biocide 
used in both strains. When growing together, the VRE strain was much 
more affected than the VSE strain and its relative fitness very low in the 
presence of benzalkonium chloride. Changes in MIC values for biocides, 
vancomycin and other antibiotics were measured after exposing both 
strains to different concentrations of benzalkonium chloride, chlorhexidine 
and triclosan. Results were similar for both strains. In particular, exposure 
to biocides induced an increment in susceptibility to penicillin. VRE strains 
had no survival advantage in the presence of biocides nor are more 
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tolerant to these compounds than VSE, suggesting that the use of these 
compounds is not acting as a pressure for selecting VRE strains. 
 
 
Introduction 
 
Enterococci are Gram-positive commensal bacteria which inhabit 
the gastro-intestinal tract of humans and other animals. Members of this 
genus have intrinsic and acquired resistance to several antibiotics and 
constitute the third most prevalent nosocomial pathogens isolated from 
bloodstream infections, and represent the most frequent cause of surgical-
site infections in intensive care units (26). Nosocomial infections caused 
by vancomycin-resistant enterococci (VRE) have been recognized as a 
problem in hospitals worldwide (12, 21, 23, 25).  
The use of biocides in the health care environment is a potential 
approach to controlling rates of VRE infections in hospitals. Enterococci 
harsh nature allows them to disseminate in a variety of other habitats, 
namely fermented foods, water, soil and plants. Due to this, the use of 
biocides also plays an important role in eradicating these bacteria in the 
food industry, agriculture and veterinary setting and in our homes. 
Biocides have been incorporated into diverse items such as surgical 
scrubs, laundry soaps, hand washes, cosmetics, toothpastes, 
mouthwashes and even in toys. Unlike antibiotics, biocides have multiple, 
non-specific modes of action to destroy bacteria and are used as 
antiseptics, disinfectants or preservatives. Usually, biocides are used at 
concentrations high enough to kill all organisms, including the resistant 
ones. Although, there is a concern related to the way they are used (for 
example surface cleaning and disinfection), as there will be areas in which 
bacteria will be exposed to sub-inhibitory concentrations (gradients of 
biocides). In this scenario, the risk of selecting bacteria less susceptible to 
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the biocidal agent used or to other antimicrobial agents increases. 
Moreover, if the nonsusceptible organism is cross-resistant to an 
antibiotic, an undesirable outcome is created as a result of biocide use: 
selection of an antibiotic-resistant microorganism (30, 34).  
Many studies have approached two questions: is the use of 
biocides selecting for antibiotic-resistant microorganisms?, and are 
antibiotic-resistant microorganisms less susceptible to biocides than 
antibiotic-susceptible ones? (for review 7, 15, 27). This problematic has 
special importance in the hospital environment, where both biocides and 
antibiotics are used more frequently and where it is easier to find 
antibiotic-resistant bacteria. Surfaces are frequently contaminated with 
VRE and other antibiotic-resistant bacteria, health care workers can easily 
contaminate their hands by touching these surfaces and therefore 
transport pathogens to other patients/environments. Biocides have to be 
effective against VRE, methicillin-resistant Staphylococcus aureus 
(MRSA) and many other bacteria. Three of the most commonly used 
biocides are chlorhexidine (CHX), used as a surgical scrub and skin 
disinfectant, triclosan (TCS), used for skin and hands disinfection, and 
benzalkonium chloride (BC), used for disinfection of surfaces. A concern 
that rises from the use of these compounds is the possibility that antibiotic-
resistant bacteria, namely VRE, could be co-resistant to these 
disinfectants. 
In this work, the correlation between susceptibility to biocides and 
vancomycin resistance was investigated. Despite other previous works 
have addressed the same question, we believe it is important to compare 
VSE and VRE isogenic strains. First MIC values for BC, CHX and TCS of 
several enterococcal isolates from different origins were measured and 
correlated with susceptibility/resistance to vancomycin of the same 
isolates. Second, for the first time, two isogenic strains (one VRE and one 
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VSE) were used in competition assays, prolonged exposure to biocides 
and fitness assays. 
 
 
Materials and Methods 
 
Bacterial strains 
A total of 83 enterococcal isolates from our collection were studied: 
35 clinical isolates, 16 veterinary isolates and 32 dairy isolates. All isolates 
have been previously identified to the species level and typed by PFGE. 
None of the 83 isolates are clones and were isolated from three different 
environments, namely Portuguese milk hard cheese, nosocomial 
infections (genito-urinary tract infections, bacteraemia/sepsis, catheter-
associated infections), and animal infections (cats and dogs isolates from 
urinary tract and skin and soft tissue infections). E. faecalis V583ermB 
(VanR) (vancomycin-resistant and erythromycin susceptible; kindly 
provided by Axel Hartke) and E. faecalis V583vanB (VanS) (vancomycin 
and erythromycin susceptible) were also used. VanR has a MIC value for 
vancomycin > 256 g/ml, while VanS as a MIC of 6 g/ml for the same 
antibiotic (both determined by E-test).  
 
Biocides and antibiotics 
Three different biocides were used in this study: benzalkonium 
chloride (Sigma-Aldrich) (BC), chlorhexidine (Fluka) (CHX) and triclosan 
(Sigma-Aldrich) (TCS). Vancomycin E-test (bioMérieux) and antibiotic 
disks (Oxoid) were used: erythromycin (E) 15 g, penicillin G (P) 10U, 
chloramphenicol (C) 30 g and methicillin (MET) 5 g.  
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Susceptibility tests 
Minimum inhibitory concentration (MIC) for TCS was determined 
by micro dilution for the 83 strains according to CLSI (10). For BC and 
CHX MIC values were already determined by us in a previous work (8) 
with the exception of five clinical isolates (four E. faecalis and one 
Enterococcus spp.) and five dairy isolates (two E. faecium, one E. durans 
and one Enterococcos spp.). Isolates obtained after prolonged exposure 
to biocides were also tested for their susceptibility to vancomycin, by E-
test, and to E, P, C and MET by disk diffusion method according to 
bioMérieaux (for E-test) and CLSI (for disk diffusion test) instructions. 
Strains were classified as susceptible, intermediate or resistance 
according to the bioMérieux criteria for E-tests and to CLSI criteria for the 
remaining antibiotic disks. 
 
Continuous exposure to vancomycin and biocides 
VanR and VanS were grown separately in 5 ml of Brain Hear 
Infusion (BHI, Oxoid) during 14 days in the presence of each antimicrobial 
agent separately. Each day, 1% of the previous overnight culture was 
passed into fresh medium containing the respective agent. At day 7 and 
day 14, the culture was stored at -20ºC for future use. Two types of 
assays were performed, one in which the antimicrobial agent 
concentration was constant (CC) in all passages and another in which the 
concentration was increasing (IC) through time. A control experiment was 
performed by passing the strains into fresh BHI without antimicrobial 
agent, every day during the same time period, using the same percentage 
of inoculum. In the case of biocides, the increases were of 0.5 g/ml each 
day until 4 g/ml and 7 g/ml, for BC (initial concentration 1 g/ml), and 3 
g/ml and 6.5 g/ml, for CHX and TCS (initial concentration 0.25 g/ml for 
both), at day 7 and day 14, respectively. The constant concentration used 
was 3 g/ml for each biocide. For vancomycin, increases were of 2 g/ml 
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each day until a final concentration of 12 g/ml at day 7, and 24 g/ml at 
day 14 (initial concentration 1 g/ml). The constant concentration used for 
this antibiotic was 8 g/ml. 
 
Detection of the vanB gene 
The presence of the vanB gene was detected using primer Fwd 
ATC GGC CTA CAT TCT TAC A and primer Rev AGC GTT TAG TTC 
TTC CGT (11).  
  
Growth curves 
100 l of an overnight culture of VanR and of VanS were incubated 
separately in 10 ml of BHI supplemented with different concentrations 
(0.25 g/ml, 0.5 g/ml, 1 g/ml and 2 g/ml) of the three tested biocides. 
Optical density (OD) at 600 nm was measure along time. For each biocide 
and each concentration, the biocide was either added at the begging of 
the assay or added when the culture reached an OD of 0.4. Controls were 
performed in the same way but without any biocide. Growth rates were 
determined at the beginning of exponential phase when biocide was 
added at the begging of the assay in at least three independent 
experiments. Strains were also incubated together in 200 ml of BHI, in 1:1 
proportion, supplemented with 1 g/ml or 2 g/ml of each biocide. OD and 
colony-forming unit (cfu) were monitorized every hour during 6h and after 
24h of incubation. In all assays, controls were performed incubating both 
strains only in BHI.  
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Fitness assays 
Competition assays were performed in 500 ml Erlenmeyers 
containing 200 ml of BHI incubated with 1 ml of an overnight culture of 
VanR and 1 ml of an overnight culture of VanS, for 24 hours at 37°C, with 
agitation. In the control situation no biocide was added to the medium. BC, 
TCS and CHX were tested separately under the same conditions and 2 
g/ml was used for each compound. At time 0h and at the end of this 
competition assay (time 24h), appropriate dilutions were platted onto BHI 
agar plates. Plates were incubated for 24h at 37ºC and 100 colonies were 
picked into BHI agar plates, without and with vancomycin (32 g/ml). 
These plates were also incubated under the same conditions and colonies 
were count after 24h. Fitness was calculated according to Turner and 
Chao (32).  Fitness (W) was defined as a relative change on the ratio 
VRE:VSE or W = (Rt/R0)/(St/S0); being R0 and S0 the cfu of VRE and VSE, 
respectively, at the beginning of the assay and Rt and St the cfu of VRE 
and VSE, respectively, at the end of the assay (24h later). 
 
Statistical analysis  
Microsoft Office Excel 2007 was used to process data on the 
frequency of vancomycin-resistance and MIC values obtained. The 
prevalence of vancomycin-resistance was compared using the Chi-
squared (χ2) test to determine statistically significant differences. Student’s 
t-test was performed using Microsoft Office Excel 2007 to compare the 
fitness value obtained in the control situation with the expected value and 
to compare the growth rate of VRE strain and VSE strain exposed to 
biocides with the control situation. All tests were two-tailed and tested at 
level of 0.05 for significance.  
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Results 
 
Susceptibility to biocides 
In order to understand if there was any association between 
susceptibility to BC, CHX and TCS, and vancomycin resistance, we 
studied several enterococcal isolates from different environments. MIC 
values for CHX and BC ranged between 1 and 8 g/ml (8). For TCS, MIC 
value was 8 g/ml for all isolates, regardless of the environment, species 
or resistance to vancomycin (Table 1). The majority of isolates from the 
three environments had MIC values of 4 g/ml for both BC and CHX. 
There was no difference between E. faecalis or E. faecium (the two most 
abundant species) in susceptibility to any of the three biocides tested. The 
same pattern was observed for both VRE and VSE isolates: 87% and 90% 
of the VSE isolates presented a MIC value ≥ 4 g/ml for BC and CHX, 
respectively; while 73% and 91% of the VRE isolates presented MIC value 
≥ 4 g/ml for the same biocides, respectively. There was no association 
between MIC values and vancomycin-resistance (p > 0.05; χ2) for any of 
the biocides tested. 
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Table 1: Distribution of enterococcal isolates from different species and environments amongst the different MIC values (g/ml) for 
BC, CHX and TCS and susceptibility to vancomycin. 
 
 
Species 
Number of isolates 
MIC BC
a 
MIC CHX
a 
MIC TCS 
1 2 4 8 2 4 8 8 
S I R S I R S I R S I R S I R S I R S I R S I R 
Clinical isolates                         
E. faecalis    2
 
2
 
1
 
4
 
8
 
5
 
   1
 
2
  
5
 
8
 
4
 
  2
 
6
 
10
 
6 
E. faecium       4
 
1
 
 5
 
  1  
 
7
 
1
 
 1
 
  9
 
1
 
 
E. hirae    1
 
  1
 
     1
 
 
 
1
 
     2
 
  
Enterococcus spp        1
 
      
 
 1
 
     1
 
 
Veterinary 
isolates 
                        
E. faecalis    3
 
  5
 
3
 
      
 
8
 
3
 
    8
 
3
 
 
E. faecium       3
 
  1
 
    
 
4      4
 
  
E. solitarius    1
 
          
 
1
 
     1
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Table 1: Continued. 
 
 
S – susceptible to vancomycin; I – intermediate to vancomycin; R – resistant to vancomycin. According to CLSI criteria (unpublished data from 
Fátima Lopes Lab). 
a
 Data from Braga et al (8). 
Species 
Number of isolates 
MIC BC
a 
MIC CHX
a 
MIC TCS 
1 2 4 8 2 4 8 8 
S I R S I R S I R S I R S I R S I R S I R S I R 
Dairy isolates                         
E. faecalis       11
 
4
 
2
 
     
 
9
 
4
 
2
 
2
 
  11 4
 
2
 
E. faecium      1
 
2
 
1
 
1
 
     1
 
2
 
1
 
1
 
   2 1
 
2
 
E. durans   1
 
   5
 
       
 
4
 
 1
 
1
 
  5
 
 1
 
E. casseliflavus       1
 
       
 
1
 
     1
 
  
E. hirae       1
 
     1
 
 
 
      1
 
  
Enterococcus spp.       2
 
     1
 
 
 
1
 
     2
 
  
Total 0 0 1 7 2 2 39 18 8 6 0 0 5 2 1 43 18 8 4 0 2 52 20 11 
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Continuous exposure to vancomycin and biocides 
VanR and VanS had the same MIC values for BC (4 g/ml), CHX (4 
g/ml) and TCS (8 g/ml). Table 2 shows the MIC values for BC, CHX, 
TCS and vancomycin of those two strains after exposure to the tested 
antimicrobial agents. When exposed to BC and CHX, both strains had a 
MIC increment of four times the initial MIC value, synonymous of 
decreasing susceptibility to these two biocides. No effect in the MIC value 
was observed in the case of exposure to TCS. The susceptibility to 
vancomycin of the studied strains was not changed upon exposure to BC 
and CHX. In contrast, after continuous exposure to TCS, VanR lost its 
resistance to vancomycin (Figure 1). vanB gene was thus searched by 
PCR and confirmed to be present in the adapted VanR strains (data not 
shown). The exposure of VanS strain to any of the three biocides did not 
lead to a decrease in vancomycin susceptibility. Exposure to vancomycin 
induced an increase in MIC values for BC and CHX, but an opposite effect 
in TCS MIC was observed in some cases, regardless of being a VRE or 
VSE strain. The exposure of VanS to vancomycin turned this strain back to 
the vancomycin resistant phenotype. 
 
 
 
 
 
 
 
 
Figure 1: Van
R
 susceptibility to vancomycin after growth in: a) BHI (control); b) BHI 
plus 3 g/ml of TCS for 7 days; c) BHI plus 3 g/ml of TCS for 14 days. 
 
 
 
 
a) b) c) 
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Table 2: MIC values for BC, CHX, TCS and VA for the two strains exposed to 
different antimicrobial agents. 
 
 
 
 
 
 
 
 
 
 
Strains 
Antimicrobial agent assay 
MIC (g/ml) 
 BC CHX TCS VA 
Van
R 
Control 
BHI
a 
4 4 8 >256 
BHI 7d 4 4 8 >256 
BHI 14 d 8 4 8 > 256 
BC 
CC-3-7d 8   >256 
IC-4-7d 8   >256 
CC-3-14d 16   >256 
IC-7-14 d 16   >256 
CHX 
CC-3-7d  16  >256 
IC-3-14d  16  >256 
CC-3-14d  16  >256 
IC-6.5-14d  16  >256 
TCS 
CC-3-7d   8 6 
IC-3-7d   8 6 
CC-3-14d   8 6 
IC-6.5-14d   8 6 
VA 
CC-8-7d 8 16 8 >256 
IC-12-7d 8 16 4 >256 
CC-8-14d 8 16 8 >256 
IC-24-14d 8 8 4 >256 
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Table 2: Continued. 
 
 
a
 Results obtained from MIC determination performed from fresh inoculum. 
 
Strains 
Antimicrobial agent assay 
MIC (g/ml) 
 BC CHX TCS VA 
Van
S 
Control 
BHI
a 
4 4 8 6 
BHI 7d 4 4 8 6 
BHI 14 d 4 4 8 6 
BC 
CC-3-7d 8   6 
IC-4-7d 8   6 
CC-3-14d 16   6 
IC-7-14 d 16   6 
CHX 
CC-3-7d  16  6 
IC-3-14d  16  6 
CC-3-14d  16  6 
IC-6.5-14d  16  6 
TCS 
CC-3-7d   8 6 
IC-3-7d   8 6 
CC-3-14d   8 6 
IC-6.5-14d   8 6 
VA 
CC-8-7d 8 16 8 >256 
IC-12-7d 8 16 8 >256 
CC-8-14d 8 16 8 >256 
IC-24-14d 8 16 4 >256 
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We also investigated if exposure to biocides induced any change 
in the susceptibility to erythromycin, penicillin G, chloramphenicol and 
methicillin. Both tested strains were susceptible to chloramphenicol and 
resistant to methicillin and exposure to the three biocides did not change 
these susceptibilities (data not shown). Differences were found in the case 
of erythromycin and penicillin G (Table 3). Exposure of both VanR and 
VanS strains to any of the biocides tested induced susceptibility to 
penicillin. TCS induced resistance to erythromycin in the VSE strain. VanS 
strain was able to keep its susceptibility to erythromycin after exposure to 
BC and CHX, as opposed to the VanR strain. However, in this strain, the 
increased resistance to erythromycin was not a result of exposure to 
biocides, as BHI cultures alone lead to erythromycin resistance by an 
unknown mechanism. 
 
Growth curves 
In order to understand if the presence of biocides induced changes 
in growth, the two isogenic strains we grown in separate in the presence 
of different concentrations of each biocide. When biocides were added at 
OD 0.4 (middle exponential phase), no differences in growth were 
observed, for any biocide nor any concentration tested (data not shown). 
When biocides were added at the beginning of the growth many 
differences were observed (Figure 2). Maximum growth rates (max) were 
calculated and values obtained are reported in Table 4.  
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Table 3: Susceptibility of Van
R
 and Van
S
 strains to erythromycin and penicillin 
assessed by disk inhibition method after exposure to BC, CHX and TCS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a
 Results of disk assays performed from fresh inoculum. 
Strains Antimicrobial agent assay 
Antibiotic 
Erythromycin Penicillin 
Halo (mm) Halo (mm) 
VanR 
Control 
BHIa 16 13.6 
BHI 7d 0 11.5 
BHI 14 d 0 11.7 
BC 
CC-3-7d 0 21.6 
IC-4-7d 0 21.1 
CC-3-14d 0 20.8 
IC-7-14 d 0 20.6 
CHX 
CC-3-7d 0 15.2 
IC-3-14d 0 21.6 
CC-3-14d 0 20.5 
IC-6.5-14d 0 20.8 
TCS 
CC-3-7d 0 17.9 
IC-3-7d 0 18.2 
CC-3-14d 0 19.9 
IC-6.5-14d 0 27.1 
VanS 
Control 
BHIa 16.3 15.3 
BHI 7d 16 13.1 
BHI 14 d 14.5 11.4 
BC 
CC-3-7d 18 21.3 
IC-4-7d 18.5 21.1 
CC-3-14d 16.6 19.8 
IC-7-14 d 17.4 19.8 
CHX 
CC-3-7d 14.9 15.4 
IC-3-14d 18.5 15.8 
CC-3-14d 12.4 21.7 
IC-6.5-14d 17 20.1 
TCS 
CC-3-7d 0 17.8 
IC-3-7d 0 19 
CC-3-14d 0 22.6 
IC-6.5-14d 0 18.8 
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Figure 2: Growth curves for Van
R
 and Van
S
 strains when biocides were added at the 
beginning of the assay. a), c) and e): growth curves of Van
R
 in the presence of BC, CHX 
and TCS, respectively; b), d) and f): growth curves of Van
S
 in the presence of BC, CHX 
and TCS, respectively. 
 
f) e) 
d) c) 
b) a) 
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Table 4: Maximum growth rate (max) calculated when biocides were added in the 
beginning of growth. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Statistically different (p < 0.05) using Student’s t-test, when compared to the control 
situation. 
nd – not determined 
 
Both VanR and VanS had similar growth rates when growing in BHI 
(control situation). The growth of VanR was affected by all concentrations 
of BC and CHX. For TCS, only 2 g/ml, the highest tested concentration, 
was able to induce an effect upon max of Van
R strain. Growth of VanS 
strain was affected only in the presence of 2 g/ml of all tested biocide. 
The max for 2 g/ml of CHX was not determined, as the lag phase lasted 
around seven hours.  
 
 max (h
-1
) 
 Van
R 
Van
S 
Control 1.53 ± 0.21 1,56 ± 0.24 
BC   
0.25 1.19 ± 0.06* 1.51 ± 0.27 
0.5 1.24 ± 0.08* 1.40 ± 0.25 
1 1.22 ± 0.11* 1.31 ± 0.19 
2 0.61 ± 0.18* 0.79 ± 0.23* 
CHX   
0.25 1.19 ± 0.15* 1.62 ± 0.31 
0.5 1.14 ± 0.07* 1.44 ± 0.21 
1 0.97 ± 0.08* 1.25 ± 0.26 
2 nd nd 
TCS   
0.25 1.62 ± 0.29 1.72 ± 0.42 
0.5 1.43 ± 0.22 1.65 ± 0.08 
1 1.40 ± 0.27 1.53 ± 0.08 
2 0.80 ± 0.21* 0.86 ± 0.28* 
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Relative fitness 
We then decided to grow both strains together in order to measure 
their relative fitness in the presence of each biocide, as this is a scenario 
closer to reality. Strains growing together behaved similarly to growth 
separately in the presence of CHX and TCS (Figure 3). However, for 2 
g/ml of BC, when VanR and VanS were together this concentration did not 
affect growth of the culture, as opposed to what was seen when strains 
grew separately in the same BC concentration (Figure 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Growth curves of Van
R
 and Van
S
 growing together in the presence of the 
each biocide: a) benzalkonium chloride; b) chlorhexidine; c) triclosan. 
 
 
a) b) 
c) 
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Fitness assays were also performed, but only for 2 g/ml of each 
biocide, as it was the concentration with which stronger effects on growth 
were observed. In the control situation, where no biocide was added, there 
was no prevalence of any strain over the other (W=1.31; p > 0.05 when 
compared with a W=1). When biocides were used, VanS had always a 
higher fitness, specially in the presence of BC and CHX (Table 5). 
 
Table 5: CFU obtained for VRE strain and VSE strain at time 0h and time 24h when 
grown together in different conditions and respective average fitness value and 
standard deviation. 
 
 
 
 
 
 
 
 
 
 
 
Conditions 
CFU 
Relative 
fitness 
VRE VSE 
t0 t24 t0 t24 
Control 
3.66x10
6 
± 
1.16X10
6 
3.99x10
8
 ± 
0.91x10
8
 
5.57x10
6
 ± 
0.93x10
6
 
4.71x10
8
 
±0.60x10
8 
1.31 ± 
0.16 
BC  
2 g/ml 
3,70x10
6 
± 
1.98x10
6 
6,50x10
7
 
 
± 
8.23x10
7 
6.24x10
6
 
 
± 
0.52x10
6 
5.45x10
8
 
 
± 
1.49x10
8
 
0.248 ± 
0.29 
CHX  
2 g/ml 
4.37x10
6
 
 
± 
0.21x10
6 
2.76x10
7
 
 
± 
4.54x10
7
  
7.35x10
6
 
 
± 
0.31x10
6
 
3.60x10
8
 
 
± 
4.17x10
8
 
0.064 
±0.07 
TCS  
2 g/ml 
5.10x10
6
 
 
± 
0.84x10
6 
7.88x10
7
 
 
± 
2.18x10
7 
6.98x10
6
 
 
± 
1.22x10
6 
1.35x10
8
 
 
± 
0.31x10
8
 
0.791 ± 
0.01 
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Discussion 
 
In this study, a total of 83 enterococci from our collection were 
studied: 35 clinical isolates, 16 veterinary isolates and 32 dairy isolates. 
The issue of VRE spread is of great concern, as this may render 
ineffective one of the last resort antibiotic, vancomycin. Several studies 
have thus addressed the question if VRE are being selected or are more 
resistant to biocides. Our results demonstrated that vancomycin 
resistance carries no advantage in tolerance to the biocides herein tested. 
Other authors (4, 9, 16, 20, 31) have also studied different VRE and VSE 
clinical isolates and concluded that antibiotic resistance does not affect the 
utility of the biocide. In another study (5) environmental isolates of 
vancomycin-resistant E. faecium from human wastewater effluents were 
characterized for susceptibility to biocides and antibiotics and compared 
with VSE strains. No correlation was found between antibiotic resistance 
and disinfectant susceptibility patterns. Baillie et al. (3) compared E. 
faecium sensitive to both vancomycin and gentamicin with vancomycin-
resistant and gentamicin-resistant strains and the results showed no 
increase in resistance to chlorhexidine as indicated by MIC. The majority 
of the studies published so far used clinical isolates, herein we compared 
clinical isolates with veterinary isolates and dairy food isolates. Although, 
all these studies, this one included, compared VRE and VSE strains from 
different genetic backgrounds and thus the differences could not be 
attributed, for sure, to differences in vancomycin resistance, as genomes 
were different. 
In our study, for the first time, two isogenic strains (one VRE and 
the other VSE) were used in order to address the question if VRE strains 
are more tolerant or have more survival advantages in the presence of 
biocides than VSE. Several assays were performed with these two strains 
and conclusions were quite consistent: VRE strain has no advantages in 
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what respects biocide tolerance when compared with its isogenic VSE.  
When both VanR and VanS were exposed to different concentration of 
each tested biocide for 7 and 14 days, their MIC values suffered the same 
increment; with the exception of TCS that did not have any effect on the 
MIC value of both strains. Fraise (13) created a BC mutant of VRE strains, 
exposing them to non-inhibitory concentrations of the biocide, centrifuging 
and applying the pellet in agar plates containing range of inhibitory levels 
of biocide. He also observed a MIC value increment for this compound (it 
duplicated). The MIC increases observed in our study may be due to 
changes in the cell membrane, activation of efflux pumps and other 
systems that are turned on during exposure. However, the exposure to 
these biocides increased the MIC values to themselves but not to 
vancomycin. It seems that the mechanisms induced in the cell by BC and 
CHX are not responsible for co-resistance to vancomycin. They probably 
do not affect the peptidoglycan structure and synthesis. VanS strain 
remained susceptible to this antibiotic even after exposure to the three 
biocides. VanR was resistant to vancomycin, yet after exposure to TCS 
lost its resistance to that antibiotic (MIC value >256 g/ml became 6 
g/ml). Triclosan inhibits bacterial enoyl-acyl carrier protein redutase (22), 
thus reducing fatty acid synthesis and consequently lipid synthesis. 
Triclosan also has a membranotropic effect, it is incorporated into the 
phospholipic membranes, probably aligning itself with the phospholipid 
acyl chains, interacting and affecting phospholipid membranes without cell 
lysis and inducing the formation of perturbed membrane structures (33). 
This may explain why VanR became susceptible to vancomycin after being 
exposed to TCS and also why the exposure to this biocide did not change 
the MIC value for itself. When the two strains were exposed to different 
concentrations of vancomycin, MIC values increased for BC and CHX but 
not to TCS. Vancomycin bound to the C-terminal D-Ala-D-Ala of the late 
peptidoglycan precursors may be delaying the action of BC and CHX and 
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may not interfere or even help the action of TCS (in some cases, a MIC 
reduction was observed). The VSE strain became resistant to vancomycin 
after being exposed to it. It is important to notice that this only happens to 
this VSE strain, but not for an original VSE strain, namely JH2-2 (results 
not shown). Could it be a mutation or compensating deletion of vanB? At 
the moment we have no explanation for this, further experiences are 
needed to understand this result. However, important is to mention that 
incubation with biocide does not have the same effect and that JH2-2 also 
does not become VRE after incubation with vancomycin.  
Changes in tolerance to other antibiotics after being exposed to 
biocides were also investigated using the two isogenic strains. The 
exposure to the biocides did not change the susceptibility pattern of any of 
the strains to chloramphenicol and methicillin, but this was not observed 
for penicillin and erythromycin. In the first case, both strains became 
susceptible to penicillin. These results suggest that exposure to biocides 
sensitize VRE and VSE to penicillin, and likely E. faecalis. These changes 
may be explained by changes in the affinity for penicillin-binding proteins 
(PBPs). Enterococci are known to have low affinity PBPs (24), which 
grants these bacteria resistance, or less susceptible to -lactam 
antibiotics. Biocides may change affinity of PBPs to penicillin, eventually 
leading to bacteria less resistance to penicillin. In the case of 
erythromycin, no inhibition halo appeared for VanR, either in the control 
situation (for 7d and 14d) or when exposed to biocides. VanS presented no 
inhibition halo after treatment with TCS. These phenomena are difficult to 
explain, as both strains (VanR and VanS) do not contain the gene 
responsible for erythromycin resistance. However, other genes (such as 
those encoding for cell envelope, transport and binding proteins) are 
important for the survival and growth maintenance of V583 treated with 
this antibiotic (1) and those maybe playing an important role in the 
resistant patterns obtained. Future work should try to analyse if any of the 
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genes referred by Aakra et al. interfere or are activated by the use of this 
biocides. In the case of VanR, we believe that the result obtained has little 
to do with the exposure to the biocide, as the strain presented an inhibition 
halo of 16 mm when the assay was performed with fresh inoculum, but 
after being for 7 and 14 days in BHI no halo was observed. 
In order to understand if VRE had any advantage over VSE during 
growth in the presence of biocides, isogenic strains were grown alone and 
together in the presence of each tested compound. When they grew 
alone, the VRE strain was more affected by the presence of biocides than 
its isogenic VSE strain, but both were specially affected by the highest 
concentration tested, 2 g/ml. When VanR and VanS were grown together, 
their behavior in the presence of these biocides was quite similar to the 
one observed when growing alone, with the exception of BC, as growth 
was not affected. 
Crossing our data from Table 4 and Table 5 gave us a new 
perspective. When both strains were together and in the absence of the 
biocides, a two log increment was observed in 24 hours. In the presence 
of all biocides at 2 g/ml, the VSE strain was able to keep this log 
increment, while the VRE strain could not. Although, VSE max was 
significantly affect in the presence of all biocides for the above mentioned 
concentration. It seems like the VRE strain is promoting or “protecting” the 
VSE strain from the biocides. This can also explain why in the presence of 
BC the growth curves were so different when strains were alone or 
together, and growth was not affected. 
The dynamics between VRE and VSE have also been approached 
in other studies. Foucault et al. (14) recently demonstrated that the 
inactivated or inducible Tn1549-enconded vanB operon was not costly to 
the enterococcal host in the absence of vancomycin. Resistant strains 
may persist for a long time if allowed to adapt to the environment (18). In 
the present study, VRE had no advantage to VSE when grown in the 
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absence of any antimicrobial agent tested, but in the presence of biocides 
it could not prevail. CHX and BC killed or inhibited VRE more than VSE, 
while TCS had a similar effect on both strains. Relative fitness of VRE to 
VSE was smaller in the presence of BC than in the presence of CHX and 
TCS. It seems that the advantage gained by VRE strains in the presence 
of vancomycin is not transferred when in the presence of biocides. 
Although, this was the first time that a fitness approach was applied to this 
problematic, more studies are required. 
Other research works have approach the problematic of VRE and 
VSE and their tolerance to biocides and commercial disinfectants, using 
other techniques such as bactericidal activity (19, 29), suspension test (2, 
28), used-dilution (17), surface test (6) and they concluded almost all the 
same. No differences between VRE and VSE strains in what concerns 
biocide tolerance. As already mentioned, all these results were obtained 
from strains with different genomes. This kind of approach is also present 
in our work and the same conclusions were taken: in what concerns BC, 
CHX and TCS, VRE strains have no surviving advantage when compared 
to VSE. We decided to go one step forward and for the first time, two 
isogenic strains (one carrying the vanB gene and the other without it) were 
studied in order to understand if the presence of this gene gave any 
advantage to the VRE strain in what concerns biocide tolerance. From our 
data, it is possible to conclude that a VRE strain has no survival 
advantage in the presence of biocides herein tested. Exposure to biocides 
increase MIC values to themselves, but does not increase resistance to 
vancomycin. Exposure to this antibiotic may have an effect on biocides 
tolerance. However, the use of biocides is not responsible for the 
prevalence of VRE in hospitals, as VRE are not more fitted to survive in 
the presence of these compounds. Constant surveillance may be required 
in hospital environment, veterinary facilities and other places where 
antibiotics and biocides are used in order to prevent future risk situations. 
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The present work represents a new approach to the interaction 
and response of enterococci to biocides. Enterococci, due to their robust 
nature, are able to survive in many different environments. During this 
research, three environments where enterococci play an important role 
were studied: clinical, veterinary and dairy food. An unexplored 
environment was screened for the presence of these bacteria: dust from 
breeding pig facilities. The biocides tested where chosen among the most 
commonly used for cleaning and disinfection of the mention environments. 
They were: benzalkonium chloride, chlorhexidine and triclosan.  
First the MIC value for the three biocides was investigated for all 
the isolates above described. This would allow understanding if in any of 
the environments in study, enterococci were more tolerant to biocides. 
Unlike antibiotics, there are no guidelines for MIC values in respect to 
biocides. Although, this methodology is still a good approach to establish a 
reference level as it gives a quantitative value, results can be easily 
reproduced and compared and it is not expensive. It was also chosen as 
other studies already used it, so a comparative analysis could be easily 
done. The values obtained for benzalkonium chloride and chlorhexidine 
for the clinical, veterinary and dairy food isolates, ranged between 2 and 8 
g/ml and for triclosan all isolates presented a MIC of 8 g/ml. Enterococci 
isolated from dust samples, presented MIC values from < 0.25 to 4 g/ml 
for benzalkonium chloride and from < 0.25 to 8 g/ml for chlorhexidine. 
Despite different origins, the MIC values obtained were very similar for the 
tested compounds. In the case of benzalkonium chloride and 
chlorhexidine, the predominant MIC value found for all isolates was 4 
g/ml. In general and independently from the environment, enterococci did 
not presented tolerance to the biocides tested and the MIC values found 
were similar to those already described in the literature (3, 4, 7, 11, 12). It 
is interesting to notice that as time passed the MIC values recorded in 
different research works are similar and did not suffer an increment.  In 
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general, for enterococci, there are no MIC values for these three 
compounds above 16 g/ml. It would be important to periodically 
monitorize environments where biocides are daily used, such as clinical 
and veterinary facilities, in order to observe if the MIC values tend to 
increase with the use of these compounds. Besides MIC tests, the 
monitorization work could also include time kill curves, surface tests 
and/or suspension tests. It would be also important to screen new 
environments where biocides and enterococci co-habit, such as homes 
and schools. 
 
An issue poorly explored concerns which mechanisms are present 
in the response of enterococci to biocides. Residual concentrations of 
biocides can be a problem, as already mention in this work, as a single 
mechanism can be responding to the biocide. The Enterococcus faecalis 
V583 pTEF1 orf EFA0010, annotated as a putative SMR transporter, was 
named during this thesis as qacZ and its role in the enterococci response 
to benzalkonium chloride, chlorhexidine and ethidium bromide was 
determined. This gene was constitutively expressed and was not induced 
by the presence of the biocides. The introduction of a high copy number 
plasmid containing this gene into V583ErmS, represented a MIC 
increment for benzalkonium chloride, but not for chlorhexidine or ethidium 
bromide. qacZ gene is involved in the response of enterococci to 
benzalkonium chloride, but not to ethidium bromide, as proven by the 
efflux assay performed (see chapter II, Figure 2). This is explained by the 
substitution of the cysteine 42 in the QacZ protein by a serine, as 
described by Paulsen et al (10) who demonstrated this substitution leads 
to a huge decrease in ability of QacC to provide resistance to EtBr. For the 
first time, for the genus Enterococcus, it was described a gene that is 
involved in the response to a QAC, benzalkonium chloride. The presence 
of this gene was investigated in the clinical, veterinary and dairy food 
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isolates, as well as a possible correlation between it and the MIC value for 
the above mention compounds. This gene was only found in clinical and 
dairy food isolates, which means that it may not yet be disseminated in the 
veterinary environment. Although, there was no association between the 
MIC value of the isolates for tested biocides and the presence/absence of 
qacZ.  
It would be interesting to screen the presence of the qacZ gene in 
more isolates, especially veterinary ones, to investigate if this gene is or is 
not yet disseminate in this environment. From this work, the presence of 
this gene is not selecting enterococci more tolerant to biocides, in 
particularly to benzalkonium chloride. To understand if its presence is not 
selecting for enterococci more tolerant to other antimicrobial agents, such 
as antibiotics would be interesting. A starting point could be to investigate 
if the enterococci isolates from dust of breeding pig facilities have this 
gene, what is its prevalence and if those who carry the qacZ are more 
tolerant to antibiotics used in veterinary practice. The above mention 
monitorization of environments such as clinical and veterinary facilities 
and new ones, should also contemplate the screening of the 
presence/absence of qacZ and the study of the relationship between MIC 
values for biocides and the prevalence of this gene. Future research 
should look for other enterococci mechanisms of response to biocides, 
how they are disseminated and if they are related or not to qacZ.  
 
In the clinical, veterinary and dairy food isolates was also 
investigated if there was any association between their MIC value for the 
three biocides tested and their susceptibility/resistance to vancomycin. 
Once more, no association was found. So, as far as it was studied during 
this thesis, the MIC value for a certain biocide is not associated neither 
with the presence/absence of qacZ gene or resistance to vancomycin. 
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Resistance to vancomycin in enterococci raises another problem in 
the matter of biocides use: if VRE are more able to survive than VSE 
when these compounds are used or if the use of biocides selects for VRE 
strains. This issue was already explored by others investigators by 
comparing the susceptibility of several VRE and VSE isolates to biocides; 
MIC testing and time-kill determination were the most common 
approaches used (2, 3, 5, 7, 12) and where, in general, no differences 
were registered. A different and new approach of this problem was done 
during this research work, two isogenic strains were used, one carrying 
the vanB gene and the other without it. These two strains were submitted 
to different experiments, such as, growth in the presence of biocides, 
continuous exposure to biocides and relative fitness assays. Data 
obtained from these experiments, lead to a conclusion where the fact of 
being a VRE does not bring any survival advantage in the presence of 
biocides and its relative fitness decrease when compared to VSE. In fact, 
the opposite effect was registered, as the VRE strain appeared to be more 
affected by the presence of biocides during its growth. The exposure to 
biocides did not turn VRE or VSE strains more resistant to penicillin G, 
chloramphenicol, meticillin and vancomycin. In fact, the exposure of the 
VRE strain to triclosan changed its MIC value for the last antibiotic; the 
strain became susceptible to vancomycin. Although, both strains became 
less tolerant to each biocide after being exposed to it for 7 and 14 days. 
Which mechanisms are involved in this response and is this less tolerance 
reversible, are question that should be answered in the future.   
This issue was also taken into account when the dust samples 
from breeding pigs were investigated. Two groups of isolates were 
screened during this study, one where enterococci were isolated using 
vancomycin in the medium and another where no antibiotic was used. For 
both groups identification to species and characterization for susceptibility 
to benzalkonium chloride and chlorhexidine was performed. The VRE 
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prevalence in the 171 Portuguese breeding pig facilities was of 17.5 %. 
This value is high, but it is inside the range of value recorded in pig feces 
and pig large intestine samples from different European countries (1, 6, 8). 
Similar environments such as superficial waters, solid waste, air and 
others presented a VRE prevalence of 26 % (9). VRE strains isolated in 
this work were also characterized for their susceptibility to biocides and 
once more no association was found between these two factors (MIC 
value for biocides and vancomycin low and high level resistance).  
Three new ST of E. faecium were discovery in dust sampled, and 
implemented in the MLST E. faecium database. The closest STs to the 
new ones were of animal origin (pig), which means that animals may be 
contaminated by the environment and/or that dust may be carrying 
enterococci that colonizes animals. Some STs from human isolates were 
also correlated with the new ones.  
Enterococci can also be transmitted from humans to animals and 
vice-versa. Although the growth promoter avoparcin is no longer used in 
veterinary practices, VRE strains are still present in breeding pig facilities 
in particular in dust. This is a question of concern, as dust can be spread 
and so disseminate VRE strains. It would be important to eradicate as 
much as possible VRE strains from animals environment and create 
monitorization practices as it is a question of bio-security to keep VRE out 
of the human food-chain. In what respects biocides, the clean and 
disinfection of pig facilities seems not to be selecting enterococci tolerant 
to benzalkonium chloride or to chlorhexidine. As far as this work can 
concern, dust from breeding pig facilities is not responsible for the 
dissemination of enterococci tolerant to any of the biocides tested. 
 
 During the development of this research work, I was confronted 
with an interesting issue: the role of the ermB gene (EFA0007) in the 
enterococci normal growth and consequently its response to biocides. 
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This gene, a ribosomal RNA adenine dimethylase, is responsible for E. 
faecalis V583 resistance to erythromycin. Although, its lack in the genome 
of this strain not only causes lost of resistance to the mention antibiotic, 
but also delays its growth. It also affects the expression of the qacZ gene 
as proven. Understanding what else happens in the cell in the absence of 
this gene and how it affects enterococci response to biocides would be an 
interesting challenge. Another interesting event was the changing of 
resistance to erythromycin of the isogenic VRE and VSE strains when 
they were grown for 7 and 14 days in BHI. Which changes occurred in the 
cell to turn a strain without the ermB gene resistant to erythromycin and if 
somehow this changes can cause any difference in the response to 
biocides is another open question. 
 
 
Enterococci have a “good relationship” with biocides. The MIC 
values described for biocides cannot be considered high when compared 
to the usually in use concentration of biocides and as far as it is known, 
these bacteria do not present tolerance to these compounds. No 
association was found between the MIC values for biocides and 
vancomycin resistance and VRE strains did not proved to have any 
survival advantage or be more tolerant to biocides than VSE strains. 
Although, as biocides are part of the daily clean and disinfection routine of 
several environment where enterococci inhabit, constant surveillance and 
more screening investigations must be required. 
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